DE102010062637A1 - Hair treatment composition, useful to treat keratin fibers, comprises e.g. Kalahari melon oil, quaternized cellulose derivative, chitosan and/or cationic alkyl polyglycosides and a fat component comprising silicones and/or oil body - Google Patents

Abstract

Hair treatment composition comprises: (a) Kalahari melon oil; (b) e.g. a quaternary ammonium compound comprising esterquats and/or quaternary imidazoline compound (I), amines and/or cationized amines, poly(methacryloyloxyethyl trimethyl ammonium compound), cationic alkyl polyglycosides, cationized honey, cationic guar derivatives, chitosan, polymeric dimethyl diallyl ammonium salts or their copolymers with esters and amides of acrylic acid and methacrylic acid, quaternized polyvinyl alcohol and/or polyquaternium; and (c) at least a fat component comprising silicones and/or oil body. Hair treatment composition comprises: (a) 0.001-5 wt.% of Kalahari melon oil; (b) 0.1-10 wt.% of a quaternary ammonium compound comprising esterquats and/or quaternary imidazoline compound of formula (I), amines and/or cationized amines, poly(methacryloyloxyethyl trimethyl ammonium compound), quaternized cellulose derivatives, preferably polyquaternium 10 and/or polyquaternium 67, cationic alkyl polyglycosides, cationized honey, cationic guar derivatives, chitosan, polymeric dimethyl diallyl ammonium salts or their copolymers with esters and amides of acrylic acid and methacrylic acid, copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and -methacrylate, vinylpyrrolidone-vinylimidazolium methochloride copolymers, quaternized polyvinyl alcohol, polyquaternium-2, -7, -16, -17, -18, -24 and/or -27; and (c) 0.1-10 wt.% of at least a fat component comprising silicones and/or oil body. R : optionally saturated, linear or branched 8-30C hydrocarbon; and A : anion. An independent claim is included for a method for treating keratin fibers, comprising applying the hair treatment composition on the keratin fibers and washing after an exposure of few seconds up to 45 minutes. [Image].

Description

The present invention relates to hair treatment compositions containing mafurabutter. Mafura butter is referred to as Trichilia emetica seed butter according to the usual nomenclature for cosmetic ingredients. The Mafurabaum belongs botanically to the family of the Meliaceae. The hair treatment compositions of the present invention contain the mafia butter as part of an active agent complex.

There is a need to further improve hair care products and to give them further advantageous properties. In particular, a care complex should be provided which can ideally also be used in conjunction with oxidizing agents and surface-active agents.

Environmental influences and oxidative hair treatments often lead to impaired combability of dry and wet hair. Furthermore, the gloss and moisture balance is adversely affected by the attacked outer structure of the keratinic fibers. Another consequence of repeated treatments of keratinic fibers with surface-active and / or oxidative agents is a strong re-greasing of the keratinic fibers and a strong tendency to increased scaling of the scalp.

It is therefore an object of the present invention to reduce the side effects of environmental influences and oxidative and surfactant hair treatments already preferably during the oxidative or surfactant hair treatment but also after the oxidative or surfactant hair treatment, without the efficiency of the oxidative or surfactant cosmetic, in particular Color intensity, color fastness, brightening power or world effect, to worsen and to prevent the greasing of the keratinic fibers and the increased formation of dandruff. In addition, in the form of a 2-in-1 product in an application step, the oxidative treatment keratinhaltiger fibers, especially human hair, with the application of an effective fiber protection from environmental influences, such as UV protection, are connected.

Mafura butter is understood to mean the butter from the seeds of the mafura fruit. The butter is obtained by conventional pressing. It is pasty at room temperature. Mafura butter is used in Africa for nutrition. The mafia butter is especially rich in fatty acids with a chain length of 16 and more carbon atoms. In cosmetic compositions, especially topical skin care applications are known. There are also hair care products are known which contain only biological ingredients.

However, there is no indication of the erfingungsgemäßen active ingredient complex and the solution of the object of the present invention.

It has now surprisingly been found that the object is achieved to a great extent by a hair treatment agent containing an active substance complex with mafurabutter. Insofar as the active ingredient complex is mentioned below, this statement refers to the ingredients a) to c) which are mandatory in the hair treatment compositions according to the invention.

This active substance complex leads to the improvement of the finishing, to the improvement of the gloss, to the improvement of the moisture balance as well as to the protection of the destructuring of keratin-containing fibers, in particular of human hair, by UV radiation and especially for the protection against oxidative damage, in particular for the maintenance of hair growth, the prevention hair loss and prevention of greasing of the keratinic fibers, and to increase the washing resistance of dyed keratinic fibers.

• a) 0,001 bis 5 Gew.-% Mafurabutter und
• b) 0,1 bis 10,0 Gew.-% einer quartären Ammoniumverbindung ausgewählt aus der Gruppe – der Esterquats und/oder – der quarternären Imidazoline der Formel I,
  
  in welcher die Reste R unabhängig voneinander jeweils für einen gesättigten oder ungesättigten, linearen oder verzweigten Kohlenwasserstoffrest mit einer Kettenlänge von 8 bis 30 Kohlenstoffatomen und A für ein physiologisch verträgliches Anion steht, und/oder – der Amine und/oder kationisierten Amine und/oder – Poly(methacryloyloxyethyltrimethylammoniumverbindungen) und/oder; – quaternisierten Cellulose-Derivaten, insbesondere Polyquaternium 10 und/oder Polyquaternium 67, und/oder – kationischen Alkylpolyglycosiden und/oder – kationisertem Honig und/oder – kationischen Guar-Derivaten und/oder – Chitosan und/oder – polymeren Dimethyldiallylammoniumsalzen und deren Copolymeren mit Estern und Amiden von Acrylsäure und Methacrylsäure und/oder – Copolymeren des Vinylpyrrolidons mit quaternierten Derivaten des Dialkylaminoalkylacrylats und -methacrylats und/oder – Vinylpyrrolidon-Vinylimidazoliummethochlorid-Copolymeren und/oder – quaterniertem Polyvinylalkohol und/oder – Polyquaternium 2 und/oder – Polyquaternium-7 und/oder – Polyquaternium-16 und/oder – Polyquaternium 17 und/oder – Polyquaternium 18 und/oder – Polyquaternium 24 und/oder – Polyquaternium 27 und
• c) 0,1 bis 10 Gew.-% mindestens einer pflegenden Fettkomponente aus den Gruppen
• c1) der Silikone und/oder
• c2) der Ölkörper.

A first subject of the present invention is therefore a hair treatment composition containing - based on its weight -

• a) 0.001 to 5 wt .-% Mafurabutter and
• b) 0.1 to 10.0% by weight of a quaternary ammonium compound selected from the group of the esterquats and / or the quaternary imidazolines of the formula I,
  
  in which the radicals R are each independently of the other a saturated or unsaturated, linear or branched hydrocarbon radical having a chain length of 8 to 30 carbon atoms and A is a physiologically acceptable anion, and / or - the amines and / or cationized amines and / or - Poly (methacryloyloxyethyltrimethylammonium compounds) and / or; Quaternized cellulose derivatives, in particular polyquaternium 10 and / or polyquaternium 67, and / or cationic alkylpolyglycosides and / or cationized honey and / or cationic guar derivatives and / or chitosan and / or polymeric dimethyldiallylammonium salts and copolymers thereof Esters and amides of acrylic acid and methacrylic acid and / or copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate and / or - vinylpyrrolidone-vinylimidazoliummethochloride copolymers and / or - quaternized polyvinyl alcohol and / or - Polyquaternium 2 and / or - Polyquaternium-7 and / or polyquaternium-16 and / or polyquaternium 17 and / or polyquaternium 18 and / or polyquaternium 24 and / or polyquaternium 27 and / or polyquaternium
• c) 0.1 to 10 wt .-% of at least one nourishing fat component from the groups
• c1) of the silicones and / or
• c2) the oil body.

In a preferred embodiment of the present invention, the cosmetic agents are used to treat keratinous fibers, in particular human hair. Preferred agents according to the invention are therefore, for example, shampoos, hair dyes, conditioners or hair tonics.

The grip defines the tactility of a fiber collective, whereby the expert sensoryly senses and evaluates the parameters fullness and suppleness of the collective.

Shaping is understood to mean the ability to give a shape change to a group of previously treated keratin-containing fibers, in particular human hair. Hair cosmetics also speak of hair styling.

By maintaining the natural growth of keratinous fibers, it is understood that the effects on natural hair growth are compensated by hair cosmetic treatments as outlined above, in particular by oxidative hair treatments, and no or at least slight effects on the natural growth of the keratinic fibers in terms of thickness growth, the growth in length and / or in relation to the hair fullness are present.

In the context of an oxidative hair treatment, the action of an oxidative cosmetic agent containing at least one oxidizing agent on hair in a cosmetic carrier is defined according to the invention.

The hair treatment composition comprising the active substance complex according to the invention is preferably used immediately before, during or after the oxidative or surfactant hair treatment. As immediately before the oxidative or surfactant hair treatment is understood within the meaning of the invention, an application directly followed by the oxidative or surfactant hair treatment, wherein the hair treatment agent containing the active ingredient complex of the invention was previously rinsed from the hair or preferably left on the hair and the hair is preferably still wet.

For the purposes of the invention, an application which follows either directly on the oxidative or surfactant hair treatment is understood as meaning after the oxidative or surfactant hair treatment, wherein the hair treatment agent containing the active substance complex according to the invention is removed after rinsing the oxidatively or surfactantly acting agent to the preferably still wet, towel-dried hair is applied, or applied to dry or wet hair only after several hours or days. In both cases, the hair treatment composition according to the invention can be rinsed out again after a contact time of a few seconds up to 45 minutes or remain completely on the hair.

The effect of the hair treatment agent according to the invention unfolds even during the oxidative or surfactant hair treatment and surprisingly persists even after intensive washing out of the hair treatment composition according to the invention.

The active substance complex according to the invention is preferably used in a cosmetic carrier. The cosmetic carriers may in particular be aqueous or aqueous-alcoholic. An aqueous cosmetic carrier contains at least 50% by weight of water. For the purposes of the present invention, aqueous-alcoholic cosmetic carriers include aqueous solutions containing 3 to 70% by weight of a C ₁ -C ₆ -alcohol, in particular methanol, ethanol or propanol, isopropanol, butanol, isobutanol, tert-butanol, n-Pentanol, iso-pentanols, n-hexanol, iso-hexanols, glycol, glycerol, 1,2-pentanediol, 1,5-pentanediol, 1,2-hexanediol or 1,6-hexanediol to understand. The compositions according to the invention may additionally contain further organic solvents, for example methoxybutanol, benzyl alcohol, ethyl diglycol or 1,2-propylene glycol. Preference is given to all water-soluble organic solvents.

As component a) of the active substance complex according to invention Mafurabutter is used. Preferably, the butter of the first pressing is used. Particularly preferred is the butter, which is obtained by a cold first pressing. A particularly preferred commercial product is the butter Ubuntu Mafura Virgin, which can be purchased by the company Aldivia. The hair treatment compositions according to the invention preferably contain the mafurabutter in an amount of from 0.001 to 5.0% by weight, particularly preferably from 0.01 to 3.0% by weight, very particularly preferably from 0.01 to 2.5% by weight. %, in each case based on the weight of the ready-to-use hair treatment agent.

A second essential ingredient b) in the hair treatment compositions is a quaternary ammonium compound. Quaternary ammonium compounds are in principle monomeric cationic or amphoteric ammonium compounds, monomeric amines, aminoamides, polymeric cationic ammonium compounds and polymeric amphoteric ammonium compounds. From this large number of possible quaternary ammonium compounds, the following groups have proven to be particularly suitable.

Esterquats according to the formula (Tkat1-2) form the first group.

• – ein verzweigter oder unverzweigter Alkylrest mit 1 bis 4 Kohlenstoffatomen, welcher mindestens eine Hydroxylgruppe enthalten kann, oder
• – ein gesättigter oder ungesättigter, verzweigter oder unverzweigter oder ein cyclischer gesättigter oder ungesättigter Alkylrest mit 6 bis 30 Kohlenstoffatomen, welcher mindestens eine Hydroxylgruppe enthalten kann, oder
• – ein Aryl oder Alkarylrest, beispielsweise Phenyl oder Benzyl,
• – den Rest (-X-R4), mit der Maßgabe, dass höchstens 2 der Reste R1, R2 oder R3 für diesen Rest stehen können:

Der Rest -(X-R4) ist mindestens 1 bis 3 mal enthalten.Here, the radicals R1, R2 and R3 are each independently and may be the same or different. The radicals R1, R2 and R3 mean:

• A branched or unbranched alkyl radical having 1 to 4 carbon atoms which may contain at least one hydroxyl group, or
• A saturated or unsaturated, branched or unbranched or cyclic saturated or unsaturated alkyl radical having from 6 to 30 carbon atoms which may contain at least one hydroxyl group, or
• An aryl or alkaryl radical, for example phenyl or benzyl,
• - the radical (-X-R4), with the proviso that at most 2 of the radicals R1, R2 or R3 can stand for this radical:

The rest - (X-R4) is contained at least 1 to 3 times.

• 1) -(CH2)n- mit n = 1 bis 20, vorzugsweise n = 1 bis 10 und besonders bevorzugt n = 1–5, oder
• 2) -(CH2-CHR5-O)n- mit n = 1 bis 200, vorzugsweise 1 bis 100, besonders bevorzugt 1 bis 50, und besonders bevorzugt 1 bis 20 mit R5 in der Bedeutung von Wasserstoff, Methyl oder Ethyl,
• 3) eine Hydroxyalkylgruppe mit ein bis vier Kohlenstoffatomen, welche verzweigt oder unverzweigt sein kann, und welche mindestens eine und höchstens 3 Hydroxygruppen enthält. Beispiele sind: -CH₂OH, -CH₂CH₂OH, -CHOHCHOH, -CH₂CHOHCH₃, -CH(CH₂OH)₂, -COH(CH₂OH)₂, -CH₂CHOHCH₂OH, -CH₂CH₂CH₂OH und Hydroxybutylreste,

und R4 steht für:

• 1) R6-O-CO-, worin R6 einen gesättigten oder ungesättigten, verzweigten oder unverzweigten oder einen cyclischen gesättigten oder ungesättigten Alkylrest mit 6 bis 30 Kohlenstoffatomen ist, welcher mindestens eine Hydroxygruppe enthalten kann, und welcher gegebenenfalls weiterhin mit 1 bis 100 Ethylenoxideinheiten und/oder 1 bis 100 Propylenoxideinheiten oxethyliert sein kann, oder
• 2) R7-CO-, worin R7 einen gesättigten oder ungesättigten, verzweigten oder unverzweigten oder einen cyclischen gesättigten oder ungesättigten Alkylrest mit 6 bis 30 Kohlenstoffatomen ist, welcher mindestens eine Hydroxygruppe enthalten kann, und welcher gegebenenfalls weiterhin mit 1 bis 100 Ethylenoxideinheiten und/oder 1 bis 100 Propylenoxideinheiten oxethyliert sein kann,

und A steht für ein physiologisch verträgliches organisches oder anorganisches Anion und wird an dieser Stelle stellvertretend für alle auch im folgenden beschriebenen Strukturen definiert. Das Anion aller beschriebenen kationischen Verbindungen ist ausgewählt aus den Halogenidionen, Fluorid, Chlorid, Bromid, Iodid, Sulfaten der allgemeinen Formel RSO₃ ^–, worin R die Bedeutung von gesättigtem oder ungesättigtem Alkylresten mit 1 bis 4 Kohlenstoffatomen hat, oder anionischen Reste organischer Säuren wie Malest, Fumarat, Oxalat, Tartrat, Citrat, Lactat oder Acetat. Solche Produkte werden beispielsweise unter den Warenzeichen Rewoquat^®, Stepantex^®, Dehyquart^®, Armocare^® und Akypoquat^® vertrieben. Die Produkte Armocare^® VGH-70, Dehyquart^® F-75, Dehyquart^® C-4046, Dehyquart^® L80, Dehyquart^® F-30, Dehyquart^® AU-35, Rewoquat^® WE18, Rewoquat^® WE38 DPG, Stepantex^® VS 90 und Akypoquat^® 131 sind Beispiele für diese Esterquats. Weitere erfindungsgemäß besonders bevorzugte Verbindungen der Formel (Tkat1-2) zählen zur Formel (Tkat1-2.1), den kationischen Betainestern.Where X stands for:

• 1) - (CH 2) n - with n = 1 to 20, preferably n = 1 to 10 and particularly preferably n = 1-5, or
• 2) - (CH 2 -CHR 5 -O) n - where n = 1 to 200, preferably 1 to 100, particularly preferably 1 to 50, and particularly preferably 1 to 20 with R 5 in the meaning of hydrogen, methyl or ethyl,
• 3) a hydroxyalkyl group of one to four carbon atoms, which may be branched or unbranched, and which contains at least one and at most 3 hydroxy groups. Examples are: -CH ₂ OH, -CH ₂ CH ₂ OH, -CHOHCHOH, -CH ₂ CHOHCH ₃ , -CH (CH ₂ OH) ₂ , -COH (CH ₂ OH) ₂ , -CH ₂ CHOHCH ₂ OH, CH ₂ CH ₂ CH ₂ OH and hydroxybutyl radicals,

and R4 stands for:

• 1) R 6 -O-CO-, wherein R 6 is a saturated or unsaturated, branched or unbranched or cyclic saturated or unsaturated alkyl radical having 6 to 30 carbon atoms, which may contain at least one hydroxy group, and which optionally further with 1 to 100 ethylene oxide units and or 1 to 100 propylene oxide units may be ethoxylated, or
• 2) R 7 -CO-, wherein R 7 is a saturated or unsaturated, branched or unbranched or cyclic saturated or unsaturated alkyl radical having 6 to 30 carbon atoms, which may contain at least one hydroxy group, and which optionally further with 1 to 100 ethylene oxide units and / or 1 to 100 propylene oxide units can be ethoxylated,

and A is a physiologically acceptable organic or inorganic anion and is defined here as representative of all structures also described below. The anion of all described cationic compounds is selected from the halide ions, fluoride, chloride, bromide, iodide, sulfates of the general formula RSO ₃ ^- , in which R has the meaning of saturated or unsaturated alkyl radicals having 1 to 4 carbon atoms, or anionic radicals of organic acids, such as Malest, fumarate, oxalate, tartrate, citrate, lactate or acetate. Such products are marketed under the trademarks Rewoquat ^®, Stepantex® ^®, Dehyquart® ^{®, ®} and Armocare® Akypoquat ^®. The products Armocare ^® VGH-70, Dehyquart ^® F-75, Dehyquart ^® C-4046 Dehyquart ^® L80, Dehyquart ^® F-30, Dehyquart ^® AU-35, Rewoquat ^® WE18, Rewoquat ^® WE38 DPG, Stepantex ^® VS 90 and Akypoquat ^® 131 are examples of these esterquats. Further compounds of the formula (Tkat1-2) which are particularly preferred according to the invention belong to the formula (Tkat1-2.1), the cationic betaine esters.

R8 corresponds in its meaning R7.

Particularly preferred are the esterquats with tradenames Armocare ^® VGH-70 are, as well as Dehyquart ^® F-75, Dehyquart ^® L80, Stepantex ^® VS 90 and Akypoquat ^® 131st

Another group are quaternary imidazoline compounds. The formula (Tkat2) shown below shows the structure of these compounds.

• 1) Wasserstoff oder
• 2) ein Alkylrest mit 1 bis 4 C-Atomen, welcher gleich oder verschieden, gesättigt oder ungesättigt sein kann, und
• 3) eine verzweigte oder unverzweigte Hydroxyalkylgruppe mit ein bis 4 Kohlenstoffatomen mit mindestens einer und höchstens drei Hydroxygruppen beispielsweise -CH₂OH, -CH₂CH₂OH, -CHOHCHOH, -CH₂CHOHCH₃, -CH(CH₂OH)₂, -COH(CH₂OH)₂, -CH₂CHOHCH₂OH, -CH₂CH₂CH₂OH und Hydroxybutylreste, und

A ein Anion wie zuvor beschrieben und
n eine ganze Zahl zwischen 1 und 10 bedeuten.The radicals R independently of one another each represent a saturated or unsaturated, linear or branched hydrocarbon radical having a chain length of 8 to 30 carbon atoms. The preferred compounds of the formula (Tkat2) contain for R the same hydrocarbon radical. The chain length of the radicals R is preferably 12 to 21 carbon atoms. A stands for an anion as previously described. Examples according to the invention are, for example, under the INCII names Quaternium-27, Quaternium-72, Quaternium-83 and Quaternium-91 are available. Quaternium-91 is most preferred according to the invention. In a particularly preferred embodiment of the invention, the compositions according to the invention furthermore comprise at least one amine and / or cationized amine, in particular an amidoamine and / or a cationized amidoamine having the following structural formulas: R1-NH- (CH _{2) n} -N ⁺ R ² R ³ R ⁴ A (Tkat3) wherein R1 is an acyl or alkyl radical having 6 to 30 carbon atoms, which may be branched or unbranched, saturated or unsaturated, and wherein the acyl radical and / or the alkyl radical may contain at least one OH group, and
R2, R3 and R4 are each independently

• 1) hydrogen or
• 2) an alkyl radical having 1 to 4 C atoms, which may be identical or different, saturated or unsaturated, and
• 3) a branched or unbranched hydroxyalkyl group having one to 4 carbon atoms having at least one and at most three hydroxy groups, for example -CH ₂ OH, -CH ₂ CH ₂ OH, -CHOHCHOH, -CH ₂ CHOHCH ₃ , -CH (CH ₂ OH) ₂ , -COH (CH ₂ OH) ₂ , -CH ₂ CHOHCH ₂ OH, -CH ₂ CH ₂ CH ₂ OH and hydroxybutyl radicals, and

A is an anion as previously described and
n is an integer between 1 and 10.

Preference is given to a composition in which the amine and / or the quaternized amine according to general formulas (Tkat3) is an amidoamine and / or a quaternized amidoamine, in which R1 is a branched or unbranched, saturated or unsaturated acyl radical having 6 to 30 C atoms, which may contain at least one OH group means. Preference is given here to a fatty acid radical of oils and waxes, in particular of natural oils and waxes. Examples of these are lanolin, bees or candellila waxes.

Also preferred are those amidoamines and / or quaternized amidoamines in which R 2, R 3 and / or R 4 in the formula (Tkat3) represent a radical according to the general formula CH ₂ CH ₂ OR 5, where R 5 is the meaning of alkyl radicals having 1 to 4 carbon atoms , Hydroxyethyl or hydrogen. The preferred size of n in the general formula (Tkat8) is an integer between 2 and 5.

The alkylamidoamines can both be present as such and converted by protonation in a correspondingly acidic solution into a quaternary compound in the composition. According to the invention, the cationic alkylamidoamines are preferred.

Examples of such inventive commercial products are Witcamine ^® 100, Incromine ^® BB, Mackine ^® 401 and other Mackine ^® grades, Adogen ^® S18V, and as a permanent cationic aminoamines: Rewoquat ^® RTM 50, Empigen ^® CSC, Swanol ^® Lanoquat DES-50, Rewoquat ^® UTM 50, Schercoquat® ^® BAS ^® Lexquat AMG-BEO, or Incroquat ^® behenyl HE.

The aforementioned cationic surfactants may be used individually or in any combination with each other, wherein amounts between 0.01 to 10 wt .-%, preferably in amounts of 0.01 to 7.5 wt .-%, and most preferably in amounts of 0.1 to 5.0 wt .-% included. The very best results are obtained with amounts of 0.1 to 3.0 wt .-% each based on the total composition of the respective agent.

Other quaternary ammonium compounds are cationic and amphoteric polymers.

The cationic and / or amphoteric polymers may be homopolymers or copolymers or polymers based on natural polymers, wherein the quaternary nitrogen groups are contained either in the polymer chain or preferably as a substituent on one or more of the monomers. The ammonium group-containing monomers may be copolymerized with non-cationic monomers. Suitable cationic monomers are unsaturated, free-radically polymerizable compounds which carry at least one cationic group, in particular ammonium-substituted vinyl monomers such as trialkylmethacryloxyalkylammonium, trialkylacryloxyalkylammonium, dialkyldiallylammonium and quaternary vinylammonium monomers having cyclic, cationic nitrogen-containing groups such as pyridinium, imidazolium or quaternary pyrrolidones, e.g. As alkylvinylimidazolium, alkylvinylpyridinium, or Alyklvinylpyrrolidon salts. The alkyl groups of these monomers are preferably lower alkyl groups such as C1 to C7 alkyl groups, more preferably C1 to C3 alkyl groups.

The ammonium group-containing monomers may be copolymerized with non-cationic monomers. Suitable comonomers are, for example, acrylamide, methacrylamide; Alkyl and dialkylacrylamide, alkyl and dialkylmethacrylamide, alkylacrylate, alkylmethacrylate, vinylcaprolactone, vinylcaprolactam, vinylpyrrolidone, vinylester, e.g. For example, vinyl acetate, vinyl alcohol, propylene glycol or ethylene glycol, wherein the alkyl groups of these monomers are preferably C1 to C7 alkyl groups, more preferably C1 to C3 alkyl groups.

From the large number of these polymers have proven to be particularly effective components of the active ingredient complex according to the invention:
Homopolymers of the general formula - {CH ₂ - [CR ¹ COO- (CH ₂ ) _m N ⁺ R ² R ³ R ⁴ ]} _n X ^- ,
in which R ¹ = -H or -CH ₃ , R ² , R ³ and R ^{4 are} independently selected from C 1-4 -alkyl, -alkenyl or -hydroxyalkyl groups, m = 1, 2, 3 or 4, n is a natural number and
X ^{- is} a physiologically acceptable organic or inorganic anion. In the context of these polymers, those are preferred according to the invention for which at least one of the following conditions applies: R ¹ is a methyl group, R ² , R ³ and R ⁴ are methyl groups, m is 2.

Suitable physiologically tolerated counterions X ^- include, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions. Preference is given to methosulfates and halide ions, in particular chloride.

A particularly suitable homopolymer is, if desired, crosslinked, poly (methacryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquaternium-37. Such products are available, for example under the names Rheocare ^® CTH (Cosmetic Rheologies) and Synthalen® ^® CR (3V Sigma) in trade.

The homopolymer is preferably used in the form of a nonaqueous polymer dispersion. Such polymer dispersions are available under the names Salcare ^® SC 95 and Salcare ^® SC 96 in the trade.

Suitable cationic polymers derived from natural polymers are cationic derivatives of polysaccharides, for example, cationic derivatives of cellulose, starch or guar. Also suitable are chitosan and chitosan derivatives. Cationic polysaccharides have the general formula GOB-N + R _a R _b R _c A ^-
G is an anhydroglucose residue, for example starch or cellulose anhydroglucose;
B is a divalent linking group, for example, alkylene, oxyalkylene, polyoxyalkylene or hydroxyalkylene;
R _a , R _b and R _c are independently alkyl, aryl, alkylaryl, arylalkyl, alkoxyalkyl or alkoxyaryl each having up to 18 carbon atoms, wherein the total number of carbon atoms in R _a , R _b and R _{c is} preferably not more than 20 is;
A ^- is a common counteranion and is preferably chloride.

Cationic, ie quaternized celluloses are available on the market with varying degrees of substitution, cationic charge density, nitrogen content and molecular weights. For example, Polyquaternium-67 is commercially available under the designations SL ^® polymer or polymer ^® SK (Amerchol) is. Other cationic celluloses are, 400 (Amerchol, INCI name Polyquaternium-10) and polymer Quatrisoft ^® LM-200 (Amerchol, INCI name Polyquaternium-24) under the names Polymer JR ^®. Other commercial products, the compounds Celquat ^® H 100 and Celquat ^® L are 200. Finally, located under the trade designation Mirustyle CP ^® of the company. Croda with Trimonium and Cocodimonium hydroxyethylcellulose a further derivatized cellulose with the INCI name Polyquaternium-72 before. Polyquaternium-72 can be used pre-dissolved both in solid form and already in aqueous solution. Particularly preferred cationic celluloses are Polyquaternium-10, Polyquaternium-24, Polyquaternium-67 and Polyquaternium-72.

Suitable cationic guar derivatives are marketed under the trade name Jaguar ^® and have the INCI name guar hydroxypropyltrimonium chloride. Also particularly suitable cationic guar derivatives also by the company. Hercules under the name N-Hance ^® commercially. Other cationic guar derivatives are marketed by the company. Cognis under the name Cosmedia® ^®. A preferred cationic guar derivative is the commercial product AquaCat® ^® from. Hercules. This raw material is already cationic

• – kationische Alkylpolyglycoside,
• – kationisierter Honig, beispielsweise das Handelsprodukt Honeyquat^® 50,
• – polymere Dimethyldiallylammoniumsalze und deren Copolymere mit Estern und Amiden von Acrylsäure und Methacrylsäure. Die unter den Bezeichnungen Merquat^®100 (Poly(dimethyldiallylammoniumchlorid)) und Merquat^®550 (Dimethyldiallylammoniumchlorid-Acrylamid-Copolymer) im Handel erhältlichen Produkte sind Beispiele für solche kationischen Polymere mit der INCI-Bezeichnung Polyquaternium-7,
• – Vinylpyrrolidon-Vinylimidazoliummethochlorid-Copolymere, wie sie unter den Bezeichnungen Luviquat^® FC 370, FC 550 und der INCI-Bezeichnung Polyquaternium-16 sowie FC 905 und HM 552 angeboten werden,
• – quaternisiertes Vinylpyrrolidon/Dimethylaminoethylmethacrylat, zum Beispiel Vinylpyrrolidon/Dimethylaminoethylmethacrylatmethosulfat Copolymer, das unter den Handelsbezeichnungen Gafquat^® 755 N und Gafquat^® 734 von der Firma Gaf Co., USA vertrieben wird und die INCI-Bezeichnung Polyquaternium-11,
• – quaternierter Polyvinylalkohol,
• – sowie die unter den Bezeichnungen Polyquaternium-2, Polyquaternium-17, Polyquaternium-18 und Polyquaternium-27 bekannten Polymeren mit quartären Stickstoffatomen in der Polymerhauptkette,
• – Vinylpyrrolidon-Vinylcaprolactam-Acrylat-Terpolymere, wie sie mit Acrylsäureestern und Acrylsäureamiden als dritter Monomerbaustein im Handel beispielsweise unter der Bezeichnung Aquaflex^® SF 40 angeboten werden.

Guar derivative. The cationic guar derivatives are preferred according to the invention. A suitable chitosan is sold, for example, by Kyowa Oil & Fat, Japan under the trade name Flonac ^®. A preferred chitosan is chitosoniumpyrrolidone is, for example, sold under the name Kytamer ^® PC by Amerchol, USA. Further chitosan derivatives are Hydagen® ^® CMF, Hydagen® ^® HCMF and Chitolam ^® NB / 101 freely available under the trade names in the trade. Further preferred cationic polymers are, for example

• Cationic alkyl polyglycosides,
• - cationized honey, for example the commercial product Honeyquat ^® 50,
• - Dimethyldiallylammoniumsalze polymeric and their copolymers with esters and amides of acrylic acid and methacrylic acid. Under the names Merquat ^® 100 (Poly (dimethyldiallylammonium chloride)) and Merquat ^® 550 (dimethyldiallylammonium chloride-acrylamide copolymer) commercially available products are examples of such cationic polymers having the INCI name Polyquaternium-7,
• - vinylpyrrolidone vinylimidazoliummethochloride copolymers, such as those offered under the names Luviquat.RTM ^® FC 370, FC 550 and the INCI name Polyquaternium-16 and FC 905 and HM 552,
• - quaternized vinylpyrrolidone / dimethylaminoethyl, for example vinylpyrrolidone / dimethylaminoethyl copolymer available under the trade names Gafquat ^® 755 N and Gafquat ^® 734, United States is marketed by Gaf Co. and the INCI name Polyquaternium-11,
• - quaternized polyvinyl alcohol,
• And the polymers known under the names Polyquaternium-2, Polyquaternium-17, Polyquaternium-18 and Polyquaternium-27 with quaternary nitrogen atoms in the polymer main chain,
• - Vinylpyrrolidone-vinylcaprolactam-acrylate terpolymers, such as those with acrylic acid esters and acrylic acid amides as a third monomer building commercially available, for example, under the name Aquaflex ^® SF 40.

• (i) Monomeren mit quartären Ammoniumgruppen der allgemeinen Formel (Mono1), R¹-CH=CR²-CO-Z-(C_nH_2n)-N⁽⁺⁾R²R³R⁴ A^(–) (Mono1) in der R¹ und R² unabhängig voneinander stehen für Wasserstoff oder eine Methylgruppe und R³, R⁴ und R⁵ unabhängig voneinander für Alkylgruppen mit 1 bis 4 Kohlenstoff-Atomen, Z eine NH-Gruppe oder ein Sauerstoffatom, n eine ganze Zahl von 2 bis 5 und das Anion einer organischen oder anorganischen Säure ist,
• (ii) Monomeren mit quartären Ammoniumgruppen der allgemeinen Formel (Mono2),
  
  worin R⁶ und R⁷ unabhängig voneinander stehen für eine (C₁ bis C₄)-Alkylgruppe, insbesondere für eine Methylgruppe und A^– das Anion einer organischen oder anorganischen Säure ist,
• (iii) monomeren Carbonsäuren der allgemeinen Formel (Mono3), R⁸-CH=CR⁹-COOH (Mono3) in denen R⁸ und R⁹ unabhängig voneinander Wasserstoff oder Methylgruppen sind.

Amphoteric polymers according to the invention are those polymers in which a cationic group is derived from at least one of the following monomers:

• (i) monomers having quaternary ammonium groups of the general formula (Mono 1), R ¹ -CH = CR ² -CO-Z- (C _n H _2n ) -N ⁽⁺⁾ R ² R ³ R ⁴ A ^(-) (Mono 1) in which R ¹ and R ² independently of one another are hydrogen or a methyl group and R ³ , R ⁴ and R ⁵ are each independently alkyl groups having 1 to 4 carbon atoms, Z is an NH group or an oxygen atom, n is an integer of 2 to 5 and the anion is an organic or inorganic acid,
• (ii) monomers having quaternary ammonium groups of the general formula (mono 2),
  
  wherein R ⁶ and R ⁷ independently of one another represent a (C ₁ to C ₄ ) -alkyl group, in particular a methyl group and A ^{- is} the anion of an organic or inorganic acid,
• (iii) monomeric carboxylic acids of the general formula (mono 3), R ⁸ -CH = CR ⁹ -COOH (mono 3) in which R ⁸ and R ^{9 are} independently hydrogen or methyl groups.

Particular preference is given to those polymers in which monomers of the type (i) are used in which R ³ , R ⁴ and R ^{5 are} methyl groups, Z is an NH group and A ^{(-) is} a halide, methoxysulfate or ethoxysulfate ion is; Acrylamidopropyltrimethylammonium chloride is a particularly preferred monomer (i). As the monomer (ii) for the polymers mentioned, acrylic acid is preferably used.

Particularly preferred amphoteric polymers are copolymers of at least one monomer (Mono1) or (Mono2) with the monomer (Mono3), in particular copolymers of the monomers (Mono2) and (Mono3). Very particularly preferably used according to the invention amphoteric polymers are copolymers from diallyl dimethyl ammonium chloride and acrylic acid. These copolymers are sold under the INCI name Polyquaternium-22, among others, with the trade name Merquat ^® 280 (Nalco).

• (iv) monomere Carbonsäureamide der allgemeinen Formel (Mono4),

in denen R¹⁰ und R¹¹ unabhängig voneinander Wasserstoff oder Methylgruppen sind und R¹² für ein Wasserstoffatom oder eine (C₁- bis C₆)-Alkylgruppe steht, enthalten.In addition, the amphoteric polymers according to the invention in addition to a monomer (Mono1) or (Mono2) and a monomer (Mono3) additionally a monomer (Mono4)

• (iv) monomeric carboxylic acid amides of the general formula (mono 4),

wherein R ¹⁰ and R ^{11 are} independently hydrogen or methyl groups and R ^{12 is} a hydrogen atom or a (C ₁ to C ₆ ) alkyl group.

Amphoteric polymers based on a comonomer (Mono4) which are very particularly preferably used according to the invention are terpolymers of diallyldimethylammonium chloride, acrylamide and acrylic acid. These copolymers are marketed ^® under the INCI name Polyquaternium-39, among others, with the trade name Merquat Plus 3330 (Nalco).

The amphoteric polymers can generally be used both directly and in salt form, which is obtained by neutralization of the polymers, for example with an alkali metal hydroxide, according to the invention.

The abovementioned cationic polymers can be used individually or in any desired combinations with each other, amounts of between 0.01 to 10% by weight, preferably, amounts of from 0.01 to 7.5% by weight and very particularly preferably in amounts of 0.1 to 5.0 wt .-% are included. The very best results are obtained with amounts of 0.1 to 3.0 wt .-% each based on the total composition of the respective agent.

As ingredient c1) of the active ingredient complex according to the invention, the agents according to the invention preferably comprise at least one silicone polymer selected from the group of dimethiconols and / or the group of amino-functional silicones and / or the group of dimethicones and / or the group of cyclomethicones. These ingredients are described below.

The dimethicones according to the invention can be both linear and branched as well as cyclic or cyclic and branched. Linear dimethicones can be represented by the following structural formula (Si1): (SiR ¹ ₃ ) -O- (SiR ² 2 -O-) _x - (SiR ¹ ₃ ) (Si ¹ )

Branched dimethicones can be represented by the structural formula (Si1.1):

The radicals R ¹ and R ² are each independently hydrogen, a methyl radical, a C ² to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical. The numbers x, y and z are integers and each run independently from 0 to 50,000. The molecular weights of the dimethicones are between 1000 D and 10,000,000 D. The viscosities are between 100 and 10,000,000 cPs measured at 25 ° C. with the aid of a glass capillary viscometer according to the Dow Corning Corporate Test Method CTM 0004 of 20 July 1970. Preferred viscosities are between 1000 and 5,000,000 cps, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps. Most preferred are viscosities around the range of about 60,000 cps. As an example, reference is made to the product "Dow Corning 200 with 60000 cSt". Particularly preferred cosmetic or dermatological preparations according to the invention are characterized in that they contain at least one silicone of the formula (Si1.2) (CH ₃ ) ₃ Si [O-Si (CH ₃ ) ₂ ] _x -O-Si (CH ₃ ) ₃ (Si 1.2), in which x is a number from 0 to 100, preferably from 0 to 50, more preferably from 0 to 20 and in particular 0 to 10.

The dimethicones (Si1) are present in the compositions according to the invention in amounts of 0.01 to 10% by weight, preferably 0.01 to 8% by weight, particularly preferably 0.1 to 7.5% by weight and in particular 0 , 1 to 5 wt .-% based on the total composition.

Finally, among the silicone compounds Dimethiconole (Si8) understood. The dimethiconols according to the invention can be both linear and branched as well as cyclic or cyclic and branched. Linear dimethiconols can be represented by the following structural formula (Si8-I): (SiOHR ¹ ₂ ) -O- (SiR ² ₂ -O-) _x - (SiOHR ¹ ₂ ) (Si 8 -I)

Branched dimethiconols can be represented by the structural formula (Si8-II):

The radicals R ¹ and R ² are each independently hydrogen, a methyl radical, a C ² to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical. The numbers x, y and z are integers and each run independently from 0 to 50,000. The molecular weights of the dimethiconols are between 1000 D and 10,000,000 D. The viscosities are between 100 and 10,000,000 cPs measured at 25 ° C. with the aid of a glass capillary viscometer according to the Dow Corning Corporate Test Method CTM 0004 of 20 July 1970. Preferred viscosities are between 1,000 and 5,000,000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.

Examples of such products include the following commercial products: Dow Coming 1-1254 Fluid, Dow Corning 2-9023 Fluid, Dow Coming 2-9026 Fluid, Abil OSW 5 (Degussa Care Specialties), Dow Coming 1401 Fluid, Dow Coming 1403 Fluid Dow Corning 1501 Fluid, Dow Corning 1784 HVF Emulsion, Dow Corning 9546 Silicone Elastomer Blend, SM555, SM2725, SM2765, SM2785 (all four aforementioned GE Silicones), Wacker-Belsil CM 1000, Wacker-Belsil CM 3092, Wacker-Belsil CM 5040, Wacker-Belsil DM 3096, Wacker-Belsil DM 3112 VP, Wacker-Belsil DM 8005 VP, Wacker-Belsil DM 60081 VP (all Wacker-Chemie GmbH mentioned above).

The dimethiconols (Si8) are present in the compositions according to the invention in amounts of from 0.01 to 10% by weight, preferably from 0.01 to 8% by weight, particularly preferably from 0.1 to 7.5% by weight and in particular 0 , 1 to 5 wt .-% of dimethiconol based on the composition. Particularly preferred agents according to the invention contain one or more amino-functional silicones. Such silicones may, for. By the formula (Si-2) M (R _a Q _b SiO _{(4-ab) / 2} ) _x (R _c SiO _{(4-c) / 2} ) _y M (Si-2)

Be described, taking in the above formula
R is a hydrocarbon or a hydrocarbon radical having 1 to about 6 carbon atoms,
Q is a polar radical of the general formula -R ¹ HZ,
wherein
R ^{1 is} a divalent linking group bonded to hydrogen and the radical Z composed of carbon and hydrogen atoms, carbon, hydrogen and oxygen atoms or carbon, hydrogen and nitrogen atoms, and
Z is an organic, amino-functional group containing at least one amino-functional group;
a assumes values in the range of about 0 to about 2,
b takes values in the range of about 1 to about 3,
a + b is less than or equal to 3, and
c is a number in the range of about 1 to about 3, and
x is a number ranging from 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25, and
y is a number ranging from about 20 to about 10,000, preferably from about 125 to about 10,000, and most preferably from about 150 to about 1,000, and
M is a suitable silicone end group, as is known in the art, preferably trimethylsiloxy.

Z is according to formula (Si-2) an organic, amino-functional radical containing at least one functional amino group. A possible formula for said Z is NH (CH ₂ ) _z NH ₂ , where z is an integer greater than or equal to 1. Another possible formula for said Z is -NH (CH ₂ ) _z (CH ₂ ) _zz NH, wherein both z and zz independently of one another are an integer greater than or equal to 1, this structure comprising diamino ring structures, such as piperazinyl. Said Z is most preferably an -NHCH ₂ CH ₂ NH ₂ radical. Another possible formula for said Z is -N (CH ₂ ) _z (CH ₂ ) _zz NX ₂ or -NX ₂ , wherein each X of X _{2 is} independently selected from the group consisting of hydrogen and alkyl groups of 1 to 12 carbon atoms, and zz is 0.

Q according to formula (Si-2) is most preferably a polar amino-functional radical of the formula -CH ₂ CH ₂ CH ₂ NHOH ₂ OH ₂ NH ₂ .

In the formula (Si-2), α assumes values in the range of 0 to 2, b takes values in the range of 2 to 3, a + b is less than or equal to 3, and c is a number in the range of 1 to 3. Suitable for the purposes of the invention are cationic silicone oils such as, for example, the commercially available products Dow Corning (DC) 929 emulsion, DC 2-2078, DC 5-7113, SM-2059 (General Electric) and SLM-55067 (Wacker).

enthalten, worin m und n Zahlen sind, deren Summe (m + n) zwischen 1 und 2000, vorzugsweise zwischen 50 und 150 beträgt, wobei n vorzugsweise Werte von 0 bis 1999 und insbesondere von 49 bis 149 und m vorzugsweise Werte von 1 bis 2000, insbesondere von 1 bis 10 annimmt.Particularly preferred agents according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (Si 3-a)

in which m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.

These silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration and are available, for example, under the name Q2-7224 (manufacturer: Dow Corning, a stabilized trimethylsilylamodimethicone).

enthalten, worin
R für -OH, eine (gegebenenfalls ethoxylierte und/oder propoxylierte) (C₁ bis C₂₀)-Alkoxygruppe oder eine -CH₃-Gruppe steht,
R' für -OH, eine (C₁ bis C₂₀)-Alkoxygruppe oder eine -CH₃-Gruppe und
m, n1 und n2 Zahlen sind, deren Summe (m + n1 + n2) zwischen 1 und 2000, vorzugsweise zwischen 50 und 150 beträgt, wobei die Summe (n1 + n2) vorzugsweise Werte von 0 bis 1999 und insbesondere von 49 bis 149 und m vorzugsweise Werte von 1 bis 2000, insbesondere von 1 bis 10 annimmt.Particular preference is also given to compositions according to the invention which contain at least one amino-functional silicone of the formula (Si-3b)

contain, in which
R is -OH, an (optionally ethoxylated and / or propoxylated) (C ₁ to C ₂₀ ) alkoxy group or a -CH ₃ group,
R 'is -OH, a (C ₁ to C ₂₀ ) alkoxy group or a -CH ₃ group and
m, n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2000, preferably between 50 and 150, the sum (n1 + n2) preferably having values from 0 to 1999 and in particular from 49 to 149 and m preferably assumes values of from 1 to 2000, in particular from 1 to 10.

These silicones are according to the INCI declaration as Amodimethicone, or as functionalized Amodimethicone, such as bis (C13-15 alkoxy) PG Amodimethicone (for example, as a commercial product: DC 8500 from Dow Corning available), trideceth-9 PG-amodimethicones (for example commercially available as a commercial product Silcare silicones SEA from Clariant). Suitable diquaternary silicones are selected from compounds of the general formula (Si3c) [R ¹ R ² R ³ N ⁺ -A-SiR ⁷ R ⁸ - (O-SiR ⁹ R ¹⁰ ) _n -O-SiR ¹¹ R ¹² -AN ⁺ R ⁴ R ⁵ R ⁶ ] 2X ^- (Si 3c) where R 1 to R 6 independently of one another are C 1 to C 22 -alkyl radicals which may contain hydroxyl groups and where preferably at least one of the radicals has at least 8 C atoms and the remaining radicals have 1 to 4 C atoms,
the radicals R 7 to R 12, independently of one another, are identical or different and denote C 1 - to C 10 -alkyl or phenyl, A represents a divalent organic compound group,
n is a number from 0 to 200, preferably from 10 to 120, more preferably from 10 to 40, and X ^{- is} an anion.

The divalent linking group is preferably a C1 to C12 alkylene or alkoxyalkylene group which may be substituted with one or more hydroxyl groups. Particularly preferred is the group - (CH ₂ ) ₃ -O-CH ₂ -CH (OH) -CH ₂ -.

The anion X ^- can be a halide ion, an acetate, an organic carboxylate or a compound of the general formula RSO ₃ ^- , in which R has the meaning of C 1 - to C 4 -alkyl radicals.

A preferred diquaternary silicone has the general formula (Si3d) [RN ⁺ Me ₂ -A- (SiMe ₂ O) _n -SiMe ₂ -AN ⁺ Me ₂ R] 2CH ₃ COO ^- (Si 3d), where A is the group - (CH ₂ ) ₃ -O-CH ₂ -CH (OH) -CH ₂ -,
R is an alkyl radical having at least 8 C atoms and n is a number from 10 to 120.

Suitable silicone polymers having two terminal quaternary ammonium groups are known under the INCI name Quaternium-80. These are dimethylsiloxanes with two terminal trialkylammonium groups. Such diquaternary polydimethylsiloxanes are marketed by Evonik under the trade names Abil ^® Quat 3270, 3272 and 3474th

According to the invention preferred hair treatment compositions are characterized in that they, based on their weight, 0.01 to 10 wt .-%, preferably 0.01 to 8 wt .-%, particularly preferably 0.1 to 7.5 wt .-% and in particular 0.2 to 5 wt .-% amino-functional silicone (s) and / or diquaternary silicone.

Another amino-functional silicone of the present invention are polyammonium-polysiloxane compounds. The polyammonium-polysiloxane compounds may be obtained for example under the trade name Baysilone® ^® GE Bayer Silicones. The products named Baysilone TP 3911, SME 253 and SFE 839 are preferred. Very particular preference is given to the use of Baysilone TP 3911 as the active component of the compositions according to the invention. The polyammonium-polysiloxane compounds are very particularly preferred in the compositions according to the invention in an amount of from 0.01 to 10% by weight, preferably from 0.01 to 7.5, particularly preferably from 0.01 to 5.0% by weight from 0.05 to 2.5% by weight each based on the total composition.

The EP 1887024 A1 describes novel cationic amino-functional silicones which in particular improve the gloss in agents for the care of surfaces, for example human hair. These cationic silicone polymers are characterized in that they have a silicone backbone and at least one polyether part and furthermore at least one part with an ammonium structure. Examples of the preferred ones cationic silicone polymers for the purposes of the present invention are in addition to the compounds of the aforementioned EP 1887024 A1 especially the compounds with the INCI designations: Silicone Quaternium-1, Silicone Quaternium-2, Silicone Quaternium-3, Silicone Quaternium-4, Silicone Quaternium-5, Silicone Quaternium-6, Silicone Quaternium-7, Silicone Quaternium-8, Silicone Quaternium-9, Silicone Quaternium-10, Silicone Quaternium-11, Silicone Quaternium-12, Silicone Quaternium-15, Silicone Quaternium-16, Silicone Quaternium-17, Silicone Quaternium-18, Silicone Quaternium-20, Silicone Quaternium-21, Silicone Quaternium-22 as well as Silicone Quaternium-2 Panthenol Succinate and Silicone Quaternium-16 / Glycidyl Dimethicone Crosspolymer. Most preferred is Silicone Quaternium-22. This raw material is sold for example by the company Evonik under the trade name Abil ^® Quat T-60th

The cationic amino-functional silicone polymers are present in the compositions according to the invention in amounts of from 0.01 to 20% by weight, preferably in amounts of from 0.05 to 10% by weight and very particularly preferably in amounts of from 0.1 to 7.5% by weight .-% contain. The very best results are obtained with amounts of 0.1 to 5 wt .-%, each based on the total composition of the respective agent.

enthalten, in der x für eine Zahl von 3 bis 200, vorzugsweise von 3 bis 10, weiter bevorzugt von 3 bis 7 und insbesondere 3, 4, 5 oder 6, steht.The cyclic dimethicones designated as cyclomethicones according to INCI are also preferably used according to the invention. Here, cosmetic or dermatological preparations according to the invention are preferred which contain at least one silicone of the formula (Si-4)

in which x is a number from 3 to 200, preferably from 3 to 10, more preferably from 3 to 7 and in particular 3, 4, 5 or 6 stands.

Agents which are likewise preferred according to the invention are characterized in that they contain at least one silicone of the formula (Si-5) R ₃ Si [O-SiR ₂ ] _x - (CH ₂ ) _n - [O-SiR ₂ ] _y -O-SiR ₃ (Si-5), in which R is identical or different radicals from the group -H, -phenyl, -benzyl, -CH ₂ -CH (CH ₃ ) Ph, the C _1-20 -alkyl radicals, preferably -CH ₃ , -CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , -CH (CH ₃ ) ₂ , -CH ₂ CH ₂ CH ₂ H ₃ , -CH ₂ CH (CH ₃ ) ₂ , -CH (CH ₃ ) CH ₂ CH ₃ , - C (CH ₃ ) ₃ , x and y are a number from 0 to 200, preferably from 0 to 10, more preferably from 0 to 7 and especially 0, 1, 2, 3, 4, 5 or 6, stand and n is a number from 0 to 10, preferably from 1 to 8 and in particular from 2, 3, 4, 5, 6.

As further silicones in addition to the dimethicones, dimethiconols, amodimethicones and / or cyclomethicones according to the invention, water-soluble silicones can be present in the compositions according to the invention.

Corresponding hydrophilic silicones are selected, for example, from the compounds of the formulas (Si-6) and / or (Si-7). Particularly preferred water-soluble silicone-based surfactants are selected from the group of dimethicone copolyols which are preferably alkoxylated, in particular polyethoxylated or polypropoxylated.

worin der Rest R steht für ein Wasserstoffatom, eine Alkylgruppe mit 1 bis 12 C-Atomen, eine Alkoxygruppe mit 1 bis 12 C-Atomen oder eine Hydroxylgruppe, die Reste R' und R'' bedeuten Alkylgruppen mit 1 bis 12 C-Atomen, x steht für eine ganze Zahl von 1 bis 100, bevorzugt von 20 bis 30, y steht für eine ganze Zahl von 1 bis 20, bevorzugt von 2 bis 10 und a und b stehen für ganze Zahlen von 0 bis 50, bevorzugt von 10 bis 30.Dimethicone copolyols are understood according to the invention as meaning preferably polyoxyalkylene-modified dimethylpolysiloxanes of the general formulas (Si-6) or (Si-7):

in which the radical R is a hydrogen atom, an alkyl group having 1 to 12 C atoms, an alkoxy group having 1 to 12 C atoms or a hydroxyl group, the radicals R 'and R "are alkyl groups having 1 to 12 C atoms, x is an integer from 1 to 100, preferably from 20 to 30, y is an integer from 1 to 20, preferably from 2 to 10, and a and b are integers from 0 to 50, preferably from 10 to 30th

Particularly preferred dimethicone copolyols according to the invention are, for example, the products sold commercially under the trade names SILWET (Union Carbide Corporation) and DOW CORNING. Particularly preferred dimethicone copolyols according to the invention are Dow Corning 190 and Dow Corning 193.

The dimethicone copolyols are present in the compositions according to the invention in amounts of from 0.01 to 10% by weight, preferably from 0.01 to 8% by weight, particularly preferably from 0.1 to 7.5% by weight and in particular from 0.1 to 5 wt .-% of dimethicone copolyol based on the composition. Ingredient c2) of the active ingredient combination according to the invention is an oil body. These are, for example, with particular preference ester oils. The ester oils are defined as follows:
Ester oils are understood as meaning the esters of C ₆ -C ₃₀ -fatty acids with C ₂ -C ₃₀ -fatty alcohols. The monoesters of the fatty acids with alcohols having 2 to 24 carbon atoms are preferred. Examples of fatty acid components used in the esters are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and Erucic acid and its technical mixtures. Examples of the fatty alcohol components in the ester oils are isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, gadoleyl alcohol, Behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures. According to the invention, particularly preferred are isopropyl myristate (IPM Rilanit ^®), isononanoic acid C16-18 alkyl ester (Cetiol ^® SN), 2-ethylhexyl palmitate (Cegesoft ^® 24), stearic acid-2-ethylhexyl ester (Cetiol ^® 868), cetyl oleate, glycerol tricaprylate, Kokosfettalkohol- caprate / caprylate (Cetiol ^® LC), n-butyl stearate, oleyl erucate (Cetiol ^® J 600), isopropyl palmitate (IPP Rilanit ^®), oleyl Oleate (Cetiol ^®), hexyl laurate (Cetiol ^® A), di-n-butyl adipate (Cetiol ^® B), myristyl myristate (Cetiol ^® MM), cetearyl isononanoate (Cetiol ^® SN), oleic acid decyl ester (Cetiol ^® V).

Of course, the ester oils may also be alkoxylated with ethylene oxide, propylene oxide, or mixtures of ethylene oxide and propylene oxide. The alkoxylation can be found both on the fatty alcohol part and on the fatty acid part and on both parts of the ester oils. However, preference is given according to the invention if the fatty alcohol was first alkoxylated and then esterified with fatty acid. In the formula (D4-II), these compounds are generally shown.

R 1 is a saturated or unsaturated, branched or unbranched, cyclic saturated cyclic unsaturated acyl radical having 6 to 30 carbon atoms,
AO is ethylene oxide, propylene oxide or butylene oxide,
X is a number between 1 and 200, preferably 1 and 100, more preferably between 1 and 50, most preferably between 1 and 20, most preferably between 1 and 10 and most preferably between 1 and 5,
R 2 represents a saturated or unsaturated, branched or unbranched cyclic saturated cyclic unsaturated alkyl, alkenyl, alkynyl, phenyl or benzyl radical having from 6 to 30 carbon atoms. Examples of fatty acid moieties used as radical R1 in the esters are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid, gadoleic acid , Behenic acid and erucic acid and their technical mixtures. Examples of the fatty alcohol moieties R2 in the ester oils are benzyl alcohol, isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol , Arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures. A particularly preferred ester oil according to the invention is obtainable, for example, under the INCI name PPG-3 benzyl ether myristate.

• – Dicarbonsäureester wie Di-n-butyladipat, Di-(2-ethylhexyl)-adipat, Di-(2-ethylhexyl)-succinat und Di-isotridecylacelaat sowie Diolester wie Ethylenglykol-dioleat, Ethylenglykol-di-isotridecanoat, Propylenglykol-di(2-ethylhexanoat), Propylenglykol-di-isostearat, Propylenglykol-di-pelargonat, Butandiol-di-isostearat, Neopentylglykoldicaprylat, sowie
• – symmetrische, unsymmetrische oder cyclische Ester der Kohlensäure mit Fettalkoholen, beispielsweise Glycerincarbonat oder Dicaprylylcarbonat (Cetiol^® CC),
• – Trifettsäureester von gesättigten und/oder ungesättigten linearen und/oder verzweigten Fettsäuren mit Glycerin,
• – Fettsäurepartialglyceride, das sind Monoglyceride, Diglyceride und deren technische Gemische. Typische Beispiele sind Mono- und/oder Diglyceride auf Basis von Capronsäure, Caprylsäure, 2-Ethylhexansäure, Caprinsäure, Laurinsäure, Isotridecansäure, Myristinsäure, Palmitinsäure, Palmoleinsäure, Stearinsäure, Isostearinsäure, Ölsäure, Elaidinsäure, Petroselinsäure, Linolsäure, Linolensäure, Elaeostearinsäure, Arachinsäure, Gadoleinsäure, Behensäure und Erucasäure sowie deren technische Mischungen. Vorzugsweise werden Ölsäuremonoglyceride eingesetzt.

Furthermore, ester oils are to be understood as meaning:

• Dicarboxylic acid esters such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate, and diol esters such as ethylene glycol dioleate, ethylene glycol diisotridecanoate, propylene glycol di (2 ethylhexanoate), propylene glycol diisostearate, propylene glycol di-pelargonate, butanediol diisostearate, neopentyl glycol dicaprylate, and the like
• - symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, for example glycerol carbonate or dicaprylyl carbonate (Cetiol ^® CC),
• Triflic acid esters of saturated and / or unsaturated linear and / or branched fatty acids with glycerol,
• - fatty acid partial glycerides, ie monoglycerides, diglycerides and their technical mixtures. Typical examples are mono- and / or diglycerides based on caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid, Gadoleic acid, behenic acid and erucic acid and their technical mixtures. Preferably, oleic acid monoglycerides are used.

The ester oils are highly preferred in the compositions according to the invention in an amount of from 0.01 to 20% by weight, preferably from 0.01 to 10.0% by weight, particularly preferably from 0.01 to 7.5% by weight from 0.1 to 5.0 wt .-% used. Of course, it is also possible according to the invention to use several ester oils at the same time.

• – pflanzliche Öle. Beispiele für solche Öle sind Sonnenblumenöl, Olivenöl, Sojaöl, Rapsöl, Mandelöl, Jojobaöl, Orangenöl, Weizenkeimöl, Pfirsichkernöl und die flüssigen Anteile des Kokosöls. Geeignet sind aber auch andere Triglyceridöle wie die flüssigen Anteile des Rindertalgs sowie synthetische Triglyceridöle.
• – flüssige Paraffinöle, Isoparaffinöle und synthetische Kohlenwasserstoffe sowie Di-n-alkylether mit insgesamt zwischen 12 bis 36 C-Atomen, insbesondere 12 bis 24 C-Atomen, wie beispielsweise Di-n-octylether, Di-n-decylether, Di-n-nonylether, Di-n-undecylether, Di-n-dodecylether, n-Hexyl-n-octylether, n-Octyl-n-decylether, n-Decyl-n-undecylether, n-Undecyl-n-dodecylether und n-Hexyl-n-Undecylether sowie Di-tert-butylether, Di-iso-pentylether, Di-3-ethyldecylether, tert.-Butyl-n-octylether, iso-Pentyl-n-octylether und 2-Methyl-pentyl-n-octylether. Die als Handelsprodukte erhältlichen Verbindungen 1,3-Di-(2-ethyl-hexyl)-cyclohexan (Cetiol^® S) und Di-n-octylether (Cetiol^® OE) können bevorzugt sein.

Further oil bodies according to the invention are:

• - vegetable oils. Examples of such oils are sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, jojoba oil, orange oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil. Also suitable, however, are other triglyceride oils such as the liquid portions of beef tallow as well as synthetic triglyceride oils.
• Liquid paraffin oils, isoparaffin oils and synthetic hydrocarbons and di-n-alkyl ethers having a total of from 12 to 36 carbon atoms, in particular 12 to 24 carbon atoms, such as, for example, di-n-octyl ether, di-n-decyl ether, di-n- nonyl ether, di-n-undecyl ether, di-n-dodecyl ether, n-hexyl n-octyl ether, n-octyl n-decyl ether, n-decyl n-undecyl ether, n-undecyl n-dodecyl ether and n-hexyl n-undecyl ether and di-tert-butyl ether, di-iso-pentyl ether, di-3-ethyldecyl ether, tert-butyl n-octyl ether, iso-pentyl n-octyl ether and 2-methyl-pentyl-n-octyl ether. The compounds are available as commercial products 1,3-di- (2-ethyl-hexyl) -cyclohexane (Cetiol ^® S), and di-n-octyl ether (Cetiol ^® OE) may be preferred.

As natural oils, for example, amaranth seed oil, apricot kernel oil, argan oil, avocado oil, babassu oil, cottonseed oil, borage seed oil, camelina oil, thistle oil, peanut oil, pomegranate seed oil, grapefruit seed oil, hemp oil, hazelnut oil, elderflower seed oil, currant seed oil, jojoba oil, cocoa butter, linseed oil, macadamia nut oil, corn oil, almond oil, marula oil , Evening primrose oil, olive oil, palm oil, rapeseed oil, rice oil, sea buckthorn pulp oil, sea buckthorn seed oil, sesame oil, shea butter, soybean oil, sunflower oil, grapeseed oil, walnut oil or wild rose oil.

Of course, the hair treatment compositions according to the invention also contain, in addition to the active ingredient combination according to the invention, other ingredients customary in cosmetic compositions. The selection of these ingredients generally depends on the intended use of the hair treatment compositions. In the case of a shampoo, for example, further surface-active substances be included. In the case of hair treatments, further cationic compounds and other care substances may be present.

In many cases, the agents contain at least one surface-active substance, with both anionic and zwitterionic, ampholytic, nonionic and cationic surface-active substances being suitable in principle. The choice of surfactants depends on the nature of the agent.

• – lineare und verzweigte Fettsäuren mit 8 bis 30 C-Atomen (Seifen),
• – Ethercarbonsäuren der Formel R-O-(CH₂-CH₂O)_x-CH₂-COOH, in der R eine lineare Alkylgruppe mit 8 bis 30 C-Atomen und x = 0 oder 1 bis 16 ist und deren Salze,
• – Acylsarcoside mit 8 bis 24 C-Atomen in der Acylgruppe,
• – Acyltauride mit 8 bis 24 C-Atomen in der Acylgruppe,
• – Acylisethionate mit 8 bis 24 C-Atomen in der Acylgruppe,
• – Sulfobernsteinsäuremono- und -dialkylester mit 8 bis 24 C-Atomen in der Alkylgruppe und Sulfobernsteinsäuremono-alkylpolyoxyethylester mit 8 bis 24 C-Atomen in der Alkylgruppe und 1 bis 6 Oxyethylgruppen.
• – lineare Alkansulfonate mit 8 bis 24 C-Atomen,
• – lineare Alpha-Olefinsulfonate mit 8 bis 24 C-Atomen,
• – Alpha-Sulfofettsäuremethylester von Fettsäuren mit 8 bis 30 C-Atomen,
• – Alkylsulfate und Alkylpolyglykolethersulfate der Formel R-O(CH₂-CH₂O)_x-OSO₃H, in der R eine bevorzugt lineare Alkylgruppe mit 8 bis 30 C-Atomen und x = 0 oder 1 bis 12 ist,
• – Hydroxysulfonate im wesentlichen entsprechend mindestens einer der beiden folgenden Formeln oder deren deren Mischungen sowie deren salzen, CH₃-(CH₂)_y-CHOR-(CH₂)_p-(CH-SO₃M)-(CH₂)_z-CH₂-O-(C_nH_2nO)_x-H, und/oder CH₃-(CH₂)_y-(CH-SO₃M)-(CH₂)_p-CHOH-(CH₂)_z-CH₂-O-(C_nH_2nO)_x-H wobei in beiden Formeln y und z = 0 oder ganze Zahlen von 1 bis 18, p = 0, 1 oder 2 und die Summe (y + z + p) eine Zahl von 12 bis 18, x = 0 oder eine Zahl von 1 bis 30 und n eine ganze Zahl von 2 bis 4 sowie M = H oder Alkali-, insbesondere Natrium, Kalium, Lithium, Erdalkali-, insbesondere Magnesium, Calcium, Zink und/oder einem Ammoniumion, welches gegebenenfalls substituiert sein kann, insbesondere Mono-, Di-, Tri- oder Tetraammoniumionen mit C1 bis C4 Alkyl-, Alkenyl- oder Arylresten,
• – sulfatierte Hydroxyalkylpolyethylen- und/oder Hydroxyalkylenpropylenglkolether der Formel R¹-(CHOSO₃M)-CHR³-(OCHR⁴-CH₂)n-OR² mit R¹, einem linearen Alkylrest mit 1 bis 24 C-Atomen, R² für einen linearen oder verzweigten, gesättigten Alkylrest mit 1 bis 24 C-Atomen, R³ für Wasserstoff oder einen linearen Alkylrest mit 1 bis 24 C-Atomen, R⁴ für Wasserstoff oder einen Methylrest und M für Wasserstoff, Ammonium, Alkylammonium, Alkanolammonium, worin die Alkyl- und Alkanolreste je 1 bis 4 C-Atome aufweisen, oder ein Metallatom ausgewählt aus Lithium, Natrium, Kalium, Calcium oder Magnesium und n für eine Zahl im Bereich von 0 bis 12 stehen und weiterhin die Gesamtzahl der in R¹ und R³ enthaltenen C-Atome 2 bis 44 beträgt,
• – Sulfonate ungesättigter Fettsäuren mit 8 bis 24 C-Atomen und 1 bis 6 Doppelbindungen,
• – Ester der Weinsäure und Zitronensäure mit Alkoholen, die Anlagerungsprodukte von etwa 2–15 Molekülen Ethylenoxid und/oder Propylenoxid an Fettalkohole mit 8 bis 22 C-Atomen darstellen,
• – Alkyl- und/oder Alkenyletherphosphate der Formel, R¹(OCH₂CH₂)_n-O-(PO-OX)-OR², in der R¹ bevorzugt für einen aliphatischen Kohlenwasserstoffrest mit 8 bis 30 Kohlenstoffatomen, R² für Wasserstoff, einen Rest (CH₂CH₂O)_nR² oder X, n für Zahlen von 1 bis 10 und X für Wasserstoff, ein Alkali- oder Erdalkalimetall oder NR³R⁴R⁵R⁶, mit R³ bis R⁶ unabhängig voneinander stehend für Wasserstoff oder einen C₁ bis C₄-Kohlenwasserstoffrest, steht,
• – sulfatierte Fettsäurealkylenglykolester der Formel RCO(AlkO)_nSO₃M in der RCO- für einen linearen oder verzweigten, aliphatischen, gesättigten und/oder ungesättigten Acylrest mit 6 bis 22 C-Atomen, Alk für CH₂CH₂, CHCH₃CH₂ und/oder CH₂CHCH₃, n für Zahlen von 0,5 bis 5 und M für ein Metall steht, wie Alkalimetall, insbesondere Natrium, Kalium, Lithium, Erdalkalimetall, insbesondere Magnesium, Calcium, Zink, oder Ammoniumion, wie ⁺NR³R⁴R⁵R⁶, mit R³ bis R⁶ unabhängig voneinander stehend für Wasserstoff oder einen C1 bis C4-Kohlenwasserstoffrest,
• – Monoglyceridsulfate und Monoglyceridethersulfate der Formel R⁸OC-(OCH₂CH₂)_x-OCH₂-[CHO(CH₂CH₂O)_yH]-CH₂O(CH₂CH₂O)_z-SO₃X, in der R⁸CO für einen linearen oder verzweigten Acylrest mit 6 bis 22 Kohlenstoffatomen, x, y und z in Summe für 0 oder für Zahlen von 1 bis 30, vorzugsweise 2 bis 10, und X für ein Alkali- oder Erdalkalimetall steht. Typische Beispiele für im Sinne der Erfindung geeignete Monoglycerid(ether)sulfate sind die Umsetzungsprodukte von Laurinsäuremonoglycerid, Kokosfettsäuremonoglycerid, Palmitinsäuremonoglycerid, Stearinsäuremonoglycerid, Ölsäuremonoglycerid und Talgfettsäuremonoglycerid sowie deren Ethylenoxidaddukte mit Schwefeltrioxid oder Chlorsulfonsäure in Form ihrer Natriumsalze. Vorzugsweise werden Monoglyceridsulfate eingesetzt, in der R⁸CO für einen linearen Acylrest mit 8 bis 18 Kohlenstoffatomen steht,
• – Amidethercarbonsäuren, R¹-CO-NR²-CH₂CH₂-O-(CH₂CH₂O)_nCH₂COOM, mit R¹ als geradkettigen oder verzweigten Alkyl- oder Alkenylrest mit einer Zahl an Kohlenstoffatomen in der Kette von 2 bis 30, n steht für eine ganze Zahl von 1 bis 20 und R² steht für Wasserstoff, einen Methyl-, Ethyl-, Propyl-, Isopropyl-, n-Butyl-, t-Butyl- oder iso-Butylrest und M steht für Wasserstoff oder ein Metall wie Alkalimetall, insbesondere Natrium, Kalium, Lithium, Erdalkalimetall, insbesondere Magnesium, Calcium, Zink, oder ein. Ammoniumion, wie ⁺NR³R⁴R⁵R⁶, mit R³ bis R⁶ unabhängig voneinander stehend für Wasserstoff oder einen C1 bis C4-Kohlenwasserstoffrest. Derartige Produkte sind beispielsweise von der Firma Chem-Y unter der Produktbezeichnung Akypo^® erhältlich.
• – Acylglutamate der Formel XOOC-CH2CH2CH(C(NH)OR)-COOX, in der RCO für einen linearen oder verzweigten Acylrest mit 6 bis 22 Kohlenstoffatomen und 0 und/oder 1, 2 oder 3 Doppelbindungen und X für Wasserstoff, ein Alkali- und/oder Erdalkalimetall, Ammonium, Alkylammonium, Alkanolammonium oder Glucammonium steht,
• – Kondensationsprodukte aus einem wasserlöslichen Salz eines wasserlöslichen Eiweißhydrolysats mit einer C8-C30-Fettsäure. Solche Produkte sind unter dem Warenzeichen Lamepon^®, Maypon^®, Gluadin^®, Hostapon^® KCG oder Amisoft^® seit langem im Handel erhältlich.
• – Alkyl- und/oder Alkenyl-Oligoglykosidcarboxylate, -sulfate, -phosphate und/oder -isethionate,
• – Acyllactylate und
• – Hydroxymischethersulfate.

Suitable anionic surfactants (tanion) in preparations according to the invention are all anionic surfactants suitable for use on the human body. Typical examples of anionic surfactants are:

• - linear and branched fatty acids with 8 to 30 carbon atoms (soaps),
• Ether carboxylic acids of the formula RO- (CH ₂ -CH ₂ O) _x -CH ₂ -COOH, in which R is a linear alkyl group having 8 to 30 C atoms and x = 0 or 1 to 16 and salts thereof,
• Acylsarcosides having 8 to 24 C atoms in the acyl group,
• Acyltaurides having 8 to 24 carbon atoms in the acyl group,
• Acyl isethionates having 8 to 24 C atoms in the acyl group,
• - Sulfobernsteinsäuremono- and dialkyl esters having 8 to 24 carbon atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethylester having 8 to 24 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups.
• - linear alkanesulfonates having 8 to 24 carbon atoms,
• - linear alpha-olefin sulfonates having 8 to 24 carbon atoms,
• Alpha-sulfofatty acid methyl esters of fatty acids having 8 to 30 C atoms,
• Alkyl sulfates and alkyl polyglycol ether sulfates of the formula RO (CH ₂ -CH ₂ O) _x -OSO ₃ H, in which R is a preferably linear alkyl group having 8 to 30 C atoms and x = 0 or 1 to 12,
• Hydroxysulfonates essentially corresponding to at least one of the following two formulas or mixtures thereof _and salts thereof, CH ₃ - (CH ₂ ) _y -CHOR- (CH ₂ ) _p - (CH-SO ₃ M) - (CH ₂ ) _z - CH ₂ -O- (C _n H _2n O) _x -H, and / or CH ₃ - (CH ₂ ) _y - (CH-SO ₃ M) - (CH ₂ ) _p -CHOH- (CH ₂ ) _z - CH ₂ -O- (C _n H _2n O) _x -H where in both formulas y and z = 0 or integers from 1 to 18, p = 0, 1 or 2 and the sum (y + z + p) one Number of 12 to 18, x = 0 or a number from 1 to 30 and n is an integer from 2 to 4 and M = H or alkali, especially sodium, potassium, lithium, alkaline earth, especially magnesium, calcium, zinc and or an ammonium ion, which may optionally be substituted, in particular mono-, di-, tri- or tetraammonium ions with C1 to C4 alkyl, alkenyl or aryl radicals,
• - Sulfated Hydroxyalkylpolyethylen- and / or Hydroxyalkylenpropylenglkolether of the formula R ¹ - (CHOSO ₃ M) -CHR ³ - (OCHR ⁴ -CH ₂ ) n-OR ² with R ¹ , a linear alkyl radical having 1 to 24 carbon atoms, R ² R ^{1 is} hydrogen or a linear alkyl radical having 1 to 24 C atoms, R ^{4 is} hydrogen or a methyl radical and M is hydrogen, ammonium, alkylammonium, alkanolammonium, wherein the alkyl and alkanol radicals each have 1 to 4 carbon atoms, or a metal atom selected from lithium, sodium, potassium, calcium or magnesium and n are a number in the range of 0 to 12 and further the total number of in R ¹ and R ³ contains C atoms 2 to 44,
• Sulfonates of unsaturated fatty acids having 8 to 24 C atoms and 1 to 6 double bonds,
• Esters of tartaric acid and citric acid with alcohols which are adducts of about 2-15 molecules of ethylene oxide and / or propylene oxide with fatty alcohols containing 8 to 22 carbon atoms,
• Alkyl and / or alkenyl ether phosphates of the formula R ¹ (OCH ₂ CH ₂ ) _n -O- (PO-OX) -OR ² , in the R ^{1 is} preferably an aliphatic hydrocarbon radical having 8 to 30 carbon atoms, R ^{2 is} hydrogen, a radical (CH ₂ CH ₂ O) _n R ² or X, n is from 1 to 10 and X is hydrogen, an alkali metal radical or alkaline earth metal or NR ³ R ⁴ R ⁵ R ⁶ , where R ³ to R ⁶ independently of one another represent hydrogen or a C ₁ to C ₄ -hydrocarbon radical,
• - Sulfated fatty acid alkylene glycol esters of the formula RCO (AlkO) _n SO ₃ M in the RCO- for a linear or branched, aliphatic, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms, Alk for CH ₂ CH ₂ , CHCH ₃ CH ₂ and / or CH ₂ CHCH ₃ , n is from 0.5 to 5 and M is a metal such as alkali metal, especially sodium, potassium, lithium, alkaline earth metal, especially magnesium, calcium, zinc, or ammonium ion such as ⁺ NR ³ R ⁴ R ⁵ R ⁶ , where R ³ to R ⁶ independently of one another represent hydrogen or a C ¹ to C ⁴ hydrocarbon radical,
• Monoglyceride sulfates and monoglyceride ether sulfates of the formula R ⁸ OC- (OCH ₂ CH ₂ ) _x -OCH ₂ - [CHO (CH ₂ CH ₂ O) _y H] -CH ₂ O (CH ₂ CH ₂ O) _z -SO ₃ X, in which R ⁸ CO is a linear or branched acyl radical having 6 to 22 carbon atoms, x, y and z are in total 0 or numbers of 1 to 30, preferably 2 to 10, and X is an alkali or alkaline earth metal. Typical examples of monoglyceride (ether) sulfates suitable for the purposes of the invention are the reaction products of lauric acid monoglyceride, coconut fatty acid monoglyceride, palmitic acid monoglyceride, stearic acid monoglyceride, oleic acid monoglyceride and tallow fatty acid monoglyceride and their ethylene oxide adducts with sulfur trioxide or chlorosulfonic acid in the form of their sodium salts. Preferably monoglyceride sulfates are used, in which R ⁸ CO is a linear acyl radical having 8 to 18 carbon atoms,
• - Amidethercarbonsäuren, R ¹ -CO-NR ² -CH ₂ CH ₂ -O- (CH ₂ CH ₂ O) _n CH ₂ COOM, with R ¹ as a straight-chain or branched alkyl or alkenyl radical having a number of carbon atoms in the chain of 2 to 30, n is an integer from 1 to 20, and R ² is hydrogen, methyl, ethyl, propyl, isopropyl, n-butyl, t-butyl or iso-butyl, and M is for hydrogen or a metal such as alkali metal, in particular sodium, potassium, lithium, alkaline earth metal, in particular magnesium, calcium, zinc, or a. Ammonium ion, such as ⁺ NR ³ R ⁴ R ⁵ R ⁶ , with R ³ to R ⁶ independently of one another represent hydrogen or a C ¹ to C ⁴ hydrocarbon radical. Such products are obtainable, for example, by the company Chem Y under the product name Akypo ^®.
• Acylglutamates of the formula XOOC-CH 2 CH 2 CH (C (NH) OR) -COOX in which RCO is a linear or branched acyl radical having 6 to 22 carbon atoms and 0 and / or 1, 2 or 3 double bonds and X is hydrogen, an alkali metal and / or alkaline earth metal, ammonium, alkylammonium, alkanolammonium or glucammonium,
• - Condensation products of a water-soluble salt of a water-soluble protein hydrolyzate with a C8-C30 fatty acid. Such products are available under the trademark Lamepon® ^®, Maypon ^®, Gluadin® ^®, Hostapon® ^® KCG or Amisoft ^® long been commercially.
• Alkyl and / or alkenyl oligoglycoside carboxylates, sulfates, phosphates and / or isethionates,
• Acyl lactylates and
• - Hydroxymix ether sulfates.

If the mild anionic surfactants contain polyglycol ether chains, it is particularly preferred that they have a narrow homolog distribution. Further, in the case of mild anionic surfactants having polyglycol ether units, it is preferable that the number of glycol ether groups is 1 to 20, preferably 2 to 15, more preferably 2 to 12. Particularly mild anionic surfactants having polyglycol ether groups with no restricted homolog distribution can be obtained, for example on the one hand the number of polyglycol ether groups is 4 to 12 and Zn or Mg ions are selected as the counterion. One example is the commercial product Texapon.RTM ^® ASV.

Particularly suitable zwitterionic surfactants are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyl dimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinates, for example cocoacylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxymethyl 3-hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and cocoacylaminoethylhydroxyethylcarboxymethylglycinate. A preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.

Ampholytic surfactants (Tampho) are understood as meaning those surface-active compounds which are capable of forming internal salts. Examples of suitable ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C Atoms in the alkyl group. Typical examples of amphoteric or zwitterionic surfactants are alkylbetaines, alkylamidobetaines, aminopropionates, aminoglycinates, imidazolinium betaines and sulfobetaines.

Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C ₁₂ -C ₁₈ acylsarcosine.

• – Anlagerungsprodukte von 2 bis 50 Mol Ethylenoxid und/oder 0 bis 5 Mol Propylenoxid an lineare und verzweigte Fettalkohole mit 6 bis 30 C-Atomen, die Fettalkoholpolyglykolether bzw. die Fettalkoholpolypropylenglykolether bzw. gemischte Fettalkoholpolyether,
• – Anlagerungsprodukte von 2 bis 50 Mol Ethylenoxid und/oder 0 bis 5 Mol Propylenoxid an lineare und verzweigte Fettsäuren mit 6 bis 30 C-Atomen, die Fettsäurepolyglykolether bzw. die Fettsäurepolypropylenglykolether bzw. gemischte Fettsäurepolyether,
• – Anlagerungsprodukte von 2 bis 50 Mol Ethylenoxid und/oder 0 bis 5 Mol Propylenoxid an lineare und verzweigte Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe, die Alkylphenolpolyglykolether bzw. die Alkylpolypropylenglykolether, bzw. gemischte Alyklphenolpolyether,
• – mit einem Methyl- oder C₂-C₆-Alkylrest endgruppenverschlossene Anlagerungsprodukte von 2 bis 50 Mol Ethylenoxid und/oder 0 bis 5 Mol Propylenoxid an lineare und verzweigte Fettalkohole mit 8 bis 30 C-Atomen, an Fettsäuren mit 8 bis 30 C-Atomen und an Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe, wie beispielsweise die unter den Verkaufsbezeichnungen Dehydol^® LS, Dehydol^® LT (Cognis) erhältlichen Typen,
• – C₁₂-C₃₀-Fettsäuremono- und -diester von Anlagerungsprodukten von 1 bis 30 Mol Ethylenoxid an Glycerin,
• – Anlagerungsprodukte von 5 bis 60 Mol Ethylenoxid an Rizinusöl und gehärtetes Rizinusöl,
• – Polyolfettsäureester, wie beispielsweise das Handelsprodukt Hydagen^® HSP (Cognis) oder Sovermol^®-Typen (Cognis),
• – alkoxilierte Triglyceride,
• – alkoxilierte Fettsäurealkylester der Formel (Tnio-1) R¹CO-(OCH₂CHR²)_wOR³ (Tnio-1) in der R¹CO für einen linearen oder verzweigten, gesättigten und/oder ungesättigten Acylrest mit 6 bis 22 Kohlenstoffatomen, R² für Wasserstoff oder Methyl, R³ für lineare oder verzweigte Alkylreste mit 1 bis 4 Kohlenstoffatomen und w für Zahlen von 1 bis 20 steht,
• – Aminoxide,
• – Hydroxymischether, R¹O[CH₂CH(CH₃)O]_x(CH₂CHR²O)_y[CH₂CH(OH)R³]_z mit R¹ stehend für einen linearen oder verzweigten, gesättigten oder ungesättigten Alkyl- und/oder Alkenylrest mit 2 bis 30 C-Atomen, R² stehend für Wasserstoff, einen Methyl-, Ethyl-, Propyl- oder iso-Propylrest, R³ stehend für einen linearen oder verzweigten Alkylrest mit 2 bis 30 C-Atomen, x stehend für 0 oder eine Zahl von 1 bis 20, Y für eine Zahl von 1 bis 30 und z stehend für die Zahl 1, 2, 3, 4 oder 5.
• – Sorbitanfettsäureester und Anlagerungeprodukte von Ethylenoxid an Sorbitanfettsäureester wie beispielsweise die Polysorbate,
• – Zuckerfettsäureester und Anlagerungsprodukte von Ethylenoxid an Zuckerfettsäureester,
• – Anlagerungsprodukte von Ethylenoxid an Fettsäurealkanolamide und Fettamine,
• – Zuckertenside vom Typ der Alkyl- und Alkenyloligoglykoside,
• – Zuckertenside vom Typ der Fettsäure-N-alkylpolyhydroxyalkylamide,
• – Fettsäureamidpolyglycolether, Fettaminpolyglycolether,
• – Mischether bzw. Mischformale und Polysorbate.

Nonionic surfactants (Tnio) are for example

• Addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide onto linear and branched fatty alcohols having 6 to 30 carbon atoms, the fatty alcohol polyglycol ethers or the fatty alcohol polypropyleneglycol ethers or mixed fatty alcohol polyethers,
• Addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear and branched fatty acids having 6 to 30 carbon atoms, the fatty acid polyglycol ethers or the fatty acid polyethers or mixed fatty acid polyethers,
• Addition products of 2 to 50 mol of ethylene oxide and / or 0 to 5 mol of propylene oxide onto linear and branched alkylphenols having 8 to 15 C atoms in the alkyl group, the alkylphenol polyglycol ethers or the alkylpolypropylene glycol ethers, or mixed alkylpolyolpolyethers,
• - with a methyl or C ₂ -C ₆ alkyl radical end-capped addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear and branched fatty alcohols having 8 to 30 carbon atoms, to fatty acids having 8 to 30 C atoms and onto alkylphenols having 8 to 15 carbon atoms in the alkyl group, such as those available under the trade names Dehydol ^® LS, LT Dehydol ^® types (Cognis),
• C ₁₂ -C ₃₀ -fatty acid mono- and diesters of addition products of 1 to 30 mol of ethylene oxide with glycerol,
• Adducts of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil,
• - polyol, such as the commercially available product ^® Hydagen HSP (Cognis) or Sovermol ^® grades (Cognis),
• - alkoxylated triglycerides,
• Alkoxylated fatty acid alkyl esters of the formula (Tnio-1) R ¹ CO- (OCH ₂ CHR ² ) _w OR ³ (Tnio-1) in the R ¹ CO is a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms, R ^{2 is} hydrogen or methyl, R ^{3 is a} linear or branched alkyl radical having 1 to 4 carbon atoms and w is a number from 1 to 20 stands,
• - amine oxides,
• - Hydroxymischether, R ¹ O [CH ₂ CH (CH ₃ ) O] _x (CH ₂ CHR ² O) _y [CH ₂ CH (OH) R ³ ] _z with R ^{1 is} a linear or branched, saturated or unsaturated alkyl R ^{2 is} hydrogen, a methyl, ethyl, propyl or isopropyl radical, R ^{3 is} a linear or branched alkyl radical having 2 to 30 C atoms, x is 0 or a number from 1 to 20, Y is a number from 1 to 30 and z is the number 1, 2, 3, 4 or 5.
• Sorbitan fatty acid esters and adducts of ethylene oxide with sorbitan fatty acid esters such as the polysorbates,
• Sugar fatty acid esters and addition products of ethylene oxide with sugar fatty acid esters,
• Adducts of ethylene oxide with fatty acid alkanolamides and fatty amines,
• - sugar surfactants of the alkyl and alkenyl oligoglycoside type,
• Sugar surfactants of the fatty acid N-alkyl polyhydroxyalkylamide type,
• Fatty acid amide polyglycol ethers, fatty amine polyglycol ethers,
• - Mischether or mixed formals and polysorbates.

Cationic surfactants of the formula (Tkat1-1) can additionally be used.

In the formula (Tkat1), R1, R2, R3 and R4 each independently represent hydrogen, a methyl group, a phenyl group, a benzyl group, a saturated, branched or unbranched alkyl group having a chain length of 8 to 30 carbon atoms, optionally with one or more hydroxy groups may be substituted. A is a physiologically acceptable anion, for example halides such as chloride or bromide and methosulfates.

Examples of compounds of formula (Tkat1) are lauryltrimethylammonium chloride, cetyltrimethylammonium chloride, cetyltrimethylammonium bromide, cetyltrimethylammonium methosulfate, dicetyldimethylammonium chloride, tricetylmethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylbenzylammonium chloride, behenyltrimethylammonium chloride, behenyltrimethylammonium bromide, behenyltrimethylammonium methosulfate.

The surfactants (T) are used in amounts of 0.05-45% by weight, preferably 0.1-30% by weight and very particularly preferably 0.5-25% by weight, based on the total amount used in accordance with the invention Medium, used.

• – Anlagerungsprodukte von 4 bis 30 Mol Ethylenoxid und/oder 0 bis 5 Mol Pro pylenoxid an lineare Fettalkohole mit 8 bis 22 C-Atomen, an Fettsäuren mit 12 bis 22 C-Atomen und an Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe,
• – C₁₂-C₂₂-Fettsäuremono- und -diester von Anlagerungsprodukten von 1 bis 30 Mol Ethylenoxid an Polyole mit 3 bis 6 Kohlenstoffatomen, insbesondere an Glycerin,
• – Ethylenoxid- und Polyglycerin-Anlagerungsprodukte an Methylglucosid-Fettsäureester, Fettsäurealkanolamide und Fettsäureglucamide,
• – C₈-C₂₂-Alkylmono- und -oligoglycoside und deren ethoxylierte Analoga, wobei Oligomerisierungsgrade von 1,1 bis 5, insbesondere 1,2 bis 2,0, und Glucose als Zuckerkomponente bevorzugt sind,
• – Gemische aus Alkyl-(oligo)-glucosiden und Fettalkoholen zum Beispiel das im Handel erhältliche Produkt Montanov^® 68,
• – Anlagerungsprodukte von 5 bis 60 Mol Ethylenoxid an Rizinusöl und gehärtetes Rizinusöl,
• – Partialester von Polyolen mit 3-6 Kohlenstoffatomen mit gesättigten Fettsäuren mit 8 bis 22 C-Atomen,
• – Sterine, sowohl aus tierischem Gewebe (Zoosterine, Cholesterin, Lanosterin) wie aus pflanzlichen Fetten (Phytosterine, Ergosterin, Stigmasterin, Sitosterin) oder aus Pilzen und Hefen (Mykosterine),
• – Phospholipide (Lecithine, Phopshatidylcholine),
• – Fettsäureester von Zuckern und Zuckeralkoholen, wie Sorbit,
• – Polyglycerine und Polyglycerinderivate wie beispielsweise Polyglycerinpoly-12-hydroxystearat (Handelsprodukt Dehymuls^® PGPH).

Emulsifiers which can be used according to the invention are, for example

• - Addition products of 4 to 30 moles of ethylene oxide and / or 0 to 5 moles per propylene oxide to linear fatty alcohols having 8 to 22 carbon atoms, to fatty acids having 12 to 22 carbon atoms and to alkylphenols having 8 to 15 carbon atoms in the alkyl group .
• C ₁₂ -C ₂₂ -fatty acid mono- and diesters of addition products of from 1 to 30 mol of ethylene oxide onto polyols having from 3 to 6 carbon atoms, in particular to glycerol,
• Ethylene oxide and polyglycerol addition products to methyl glucoside fatty acid esters, fatty acid alkanolamides and fatty acid glucamides,
• C ₈ -C ₂₂ -alkylmono- and -oligoglycosides and their ethoxylated analogues, preference being given to degrees of oligomerization of from 1.1 to 5, in particular from 1.2 to 2.0, and glucose as the sugar component,
• Glucosides mixtures of alkyl (oligo) and fatty alcohols, for example, the commercially available product ^® Montanov 68, -
• Adducts of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil,
• Partial esters of polyols having 3-6 carbon atoms with saturated fatty acids having 8 to 22 C atoms,
• - sterols, both from animal tissue (zoosterols, cholesterol, lanosterol) and from vegetable fats (phytosterols, ergosterol, stigmasterol, sitosterol) or from fungi and yeasts (mycosterols),
• - phospholipids (lecithins, phopshatidylcholines),
• Fatty acid esters of sugars and sugar alcohols, such as sorbitol,
• - Polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate (commercial product Dehymuls ^® PGPH).

The agents according to the invention preferably contain the emulsifiers in amounts of 0.1-25% by weight, in particular 0.5-15% by weight, based on the total agent.

With particular preference the compositions according to the invention contain fatty substances (fat) as further active ingredient. Fat substances (fat) are understood to mean fatty acids, fatty alcohols, natural and synthetic waxes, which can be in solid form as well as liquid in aqueous dispersion, and natural and synthetic cosmetic oil components.

As fatty acids (Fatac) can be used linear and / or branched, saturated and / or unsaturated fatty acids having 6-30 carbon atoms. Preferred are fatty acids with 10-22 carbon atoms. Among these could be mentioned, for example, isostearic as the commercial products Emersol ^® 871 and Emersol ^® 875, and isopalmitic acids such as the commercial product Edenor ^® IP 95, and all other products sold under the trade names Edenor ^® (Cognis) fatty acids. Further typical examples of such fatty acids are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic as well as their technical mixtures. Particularly preferred are usually the fatty acid cuttings obtainable from coconut oil or palm oil; In particular, the use of stearic acid is usually preferred.

The amount used is 0.1-15 wt .-%, based on the total agent. Preferably, the amount is 0.5-10 wt .-%, with very particularly advantageous amounts of 1-5 wt .-% may be.

As fatty alcohols (fatal) it is possible to use saturated, mono- or polyunsaturated, branched or unbranched fatty alcohols with C ₆ -C ₃₀ -, preferably C ₁₀ -C ₂₂ - and very particularly preferably C ₁₂ -C ₂₂ -carbon atoms. Decanols, octanols, dodecadienol, decadienol, oleyl alcohol, eruca alcohol, ricinoleic alcohol, stearyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, arachidyl alcohol, caprylic alcohol, capric alcohol, linoleyl alcohol, linolenyl alcohol and behenyl alcohol are, for example, decanol, octanolol, dodecadienol, decadienol , as well as their Guerbet alcohols, this list should have exemplary and non-limiting character. However, the fatty alcohols are derived from preferably natural fatty acids, which can usually be based on recovery from the esters of fatty acids by reduction. Also usable according to the invention are those fatty alcohol cuts which represent a mixture of different fatty alcohols. Such substances are, for example, under the names Stenol ^® , z. B. Stenol ^® 1618 or Lanette ^®, z. B. Lanette ^® O or Lorol ^®, z. B. Lorol® ^® C8, Lorol® ^® C14, C18 Lorol® ^{®, ®} Lorol® C8-18, HD Ocenol ^®, Crodacol ^®, z. B. Crodacol CS ^{®, ®} Novol, Eutanol ^® G, Guerbitol ^® 16, Guerbitol ^® 18, Guerbitol ^® 20, Isofol ^® 12, Isofol ^® 16, Isofol ^® 24, Isofol ^® 36, Isocarb 12 ^{®, ®} Isocarb 16 or Isocarb ^® 24 for sale. Of course, wool wax alcohols, as are commercially available, for example under the names of Corona ^®, White Swan ^®, Coronet ^® or Fluilan ^® can be used according to the invention. The fatty alcohols are used in amounts of 0.1-30 wt .-%, based on the total preparation, preferably in amounts of 0.1-20 wt .-%. As natural or synthetic waxes (Fatwax) it is possible according to the invention to use solid paraffins or isoparaffins, Carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, spermaceti, sunflower wax, fruit waxes such as apple wax or citrus wax, microwaxes of PE or PP. Such waxes are available, for example, from Kahl & Co., Trittau.

The amount used is 0.1-50 wt .-% based on the total agent, preferably 0.1-20 wt .-% and particularly preferably 0.1-15 wt .-% based on the total agent.

The total amount of oil and fat components in the inventive compositions is usually 0.5-75 wt .-%, based on the total mean. Amounts of 0.5-35 wt .-% are preferred according to the invention.

Another inventive synergistic active ingredient in the compositions according to the invention with the active ingredient complex according to the invention are protein hydrolysates and / or derivatives thereof (P).

According to the invention, protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used.

Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolysates, which may also be present in the form of salts. Such products are, for example, under the trademarks Dehylan ^® (Cognis), Promois® ^® (Interorgana) Collapuron ^® (Cognis), Nutrilan® ^® (Cognis), Gelita-Sol ^® (German Gelatinefabriken Stoess & Co), Lexein ^® (Innlex) and kerasol tm ^® (Croda) sold.

Further preferred vegetable protein hydrolysates according to the invention are, for example, soybean, almond, pea, moringa, potato and wheat protein hydrolysates. Such products are, for example, under the trademarks Gluadin ^® (Cognis), diamine ^® (Diamalt) ^® (Innlex) Hydrosog ^® (Croda), hydro Lupine ^® (Croda), hydro Sesame ^® (Croda), Hydro tritium ^® (Croda), Crotein ^® (Croda) and Puricare ^® LS 9658 from the Laboratoires Sérobiologiques available.

Further preferred protein hydrolysates according to the invention are of maritime origin. These include, for example, collagen hydrolyzates of fish or algae as well as protein hydrolysates of mussels or pearl hydrolyzates. Examples of pearl extracts according to the invention are the commercial products Pearl Protein Extract BG ^® or Crodarom ^® Pearl.

Furthermore, cationized protein hydrolysates are to be counted among the protein hydrolysates and their derivatives, wherein the underlying protein hydrolyzate from the animal, for example from collagen, milk or keratin, from the plant, for example from wheat, maize, rice, potatoes, soya or almonds, from marine life forms , for example from fish collagen or algae, or biotechnologically derived protein hydrolysates, may originate. As typical examples of the cationic protein hydrolyzates and derivatives according to the invention, those mentioned under the INCI names in "International Cosmetic Ingredient Dictionary and Handbook," (seventh edition 1997, The Cosmetic, Toiletry and Fragrance Association 1101 17th Street, NW, suite 300, Washington, DC 20036-4702) mentioned and commercially available products called.

The protein hydrolysates (P) are present in the compositions at levels of from 0.001% to 20%, preferably from 0.05% to 15% and most preferably in amounts of 0, 05 wt .-% up to 5 wt .-% included.

Another preferred group of ingredients of the compositions according to the invention with the active ingredient complex according to the invention are vitamins, provitamins or vitamin precursors. Vitamins, pro-vitamins and vitamin precursors are particularly preferred, which are assigned to the groups A, B, C, E, F and H.

The group of substances called vitamin A includes retinol (vitamin A ₁ ) and 3,4-didehydroretinol (vitamin A ₂ ). The β-carotene is the provitamin of retinol. As vitamin A component according to the invention, for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate into consideration. The agents according to the invention preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the total preparation.

The vitamin B group or the vitamin B complex include:
Vitamin B ₁ (thiamine)
Vitamin B ₂ (riboflavin)
Vitamin B ₃ . Under this name, the compounds nicotinic acid and nicotinamide (niacinamide) are often performed. Preferred according to the invention is the nicotinic acid amide which is contained in the agents used according to the invention preferably in amounts of from 0.05 to 1% by weight, based on the total agent.

Vitamin B ₅ (pantothenic acid, panthenol and pantolactone). Panthenol and / or pantolactone are preferably used in the context of this group. Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols. Individual representatives are, for example, panthenol triacetate, panthenol monoethyl ether and its monoacetate, as well as cationic panthenol derivatives. Pantothenic acid is preferably used as a derivative in the form of the more stable calcium salts and sodium salts (Ca-pantothenate, Na-pantothenate) in the present invention.

Vitamin B ₆ (pyridoxine and pyridoxamine and pyridoxal).

The stated compounds of the vitamin B type, in particular vitamin B ₃ , B ₅ and B ₆ , are preferably present in the agents according to the invention in amounts of 0.05-10% by weight, based on the total agent. Amounts of 0.1-5 wt .-% are particularly preferred.

Vitamin C (ascorbic acid). Vitamin C is used in the agents according to the invention preferably in amounts of 0.1 to 3 wt .-%, based on the total agent. Use in the form of palmitic acid ester, glucosides or phosphates may be preferred. The use in combination with tocopherols may also be preferred.

Vitamin E (tocopherols, especially α-tocopherol). Tocopherol and its derivatives, which include in particular the esters such as the acetate, the nicotinate, the phosphate and the succinate, are preferably present in the agents according to the invention in amounts of 0.05-1% by weight, based on the total agent.

Vitamin F. The term "vitamin F" is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.

Vitamin H. Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] -imidazole-4-valeric acid, for which, however, the trivial name biotin has meanwhile become established. Biotin is preferably present in the compositions according to the invention in amounts of from 0.0001 to 1.0% by weight, in particular in amounts of from 0.001 to 0.01% by weight.

The compositions according to the invention preferably contain vitamins, provitamins and vitamin precursors from groups A, B, E and H. Panthenol, pantolactone, pyridoxine and its derivatives as well as nicotinic acid amide and biotin are particularly preferred.

A particularly preferred group of ingredients in the cosmetic compositions according to the invention are the betaines mentioned below: carnitine, carnitine tartrate, carnitine magnesium citrate, acetyl carnitine, betalain, 1,1-dimethyl-proline, choline, choline chloride, choline bitartrate, choline dihydrogen citrate and those described in the literature Betaine designated compound N, N, N-trimethylglycine.

Carnitine, histidine, choline and betaine are preferably used. In a particularly preferred embodiment of the invention, the active ingredient used is L-carnitine tartrate.

In a further embodiment preferred according to the invention, the compositions according to the invention contain biochinones. In the agents according to the invention, suitable biochinones are understood as meaning one or more ubiquinone (s) and / or plastoquinone (s). The preferred ubiquinones according to the invention have the following formula:

Coenzyme Q-10 is most preferred.

Preferred compositions of the invention contain purine and / or purine derivatives in narrower ranges. Here, preferred cosmetic compositions according to the invention are characterized in that they contain, based on their weight, from 0.001 to 2.5% by weight, preferably from 0.0025 to 1% by weight, particularly preferably from 0.005 to 0.5% by weight and in particular from 0.01 to 0.1% by weight of purine (s) and / or purine derivative (s). Cosmetic agents preferred according to the invention are characterized in that they contain purine, adenine, guanine, uric acid, hypoxanthine, 6-purinethiol, 6-thioguanine, xanthine, caffeine, theobromine or theophylline. In hair cosmetic preparations, caffeine is most preferred.

In a further preferred embodiment of the present invention, the cosmetic agent contains ectoine ((S) -2-methyl-1,4,5,6-tetrahydro-4-pyrimidinecarboxylic acid.

Particularly preferred according to the invention are agents which, based on their weight, are from 0.00001 to 10.0% by weight, preferably from 0.0001 to 5.0% by weight and in particular from 0.001 to 3% by weight, of the active compounds from Group formed by carnitine, coenzyme Q-10, ectoine, a B-series vitamin, a purine and its derivatives or physiologically acceptable salts.

A particularly preferred care additive in the hair treatment compositions according to the invention is taurine. Taurine is understood to mean exclusively 2-aminoethanesulfonic acid and a derivative to the explicitly mentioned derivatives of taurine. Derivatives of taurine include N-monomethyltaurine, N, N-dimethyltaurine, tauryllysylate, taurine tartrate, taurine ornithithate, lysyltaurine and ornithyl taurine.

Particularly preferred are agents according to the invention, which - based on their weight - 0.0001 to 10.0 wt .-%, preferably 0.0005 to 5.0 wt .-%, particularly preferably 0.001 to 2.0 wt .-% and In particular, 0.001 to 1.0 wt .-% taurine and / or a derivative of taurine included. The effect of the compositions according to the invention can be further enhanced by a 2-pyrrolidinone-5-carboxylic acid and its derivatives (J). Preference is given to the sodium, potassium, calcium, magnesium or ammonium salts in which the ammonium ion carries, in addition to hydrogen, one to three C ₁ - to C ₄ -alkyl groups. The sodium salt is most preferred. The amounts used in the compositions according to the invention are 0.05 to 10 wt .-%, based on the total agent, more preferably 0.1 to 5, and especially 0.1 to 3 wt .-%.

By using plant extracts as care substances, the hair treatment compositions according to the invention can be formulated in a particularly natural and yet very effective way in their care performance. Optionally, even otherwise customary preservatives can be dispensed with. According to the invention are especially the extracts of green tea, oak bark, nettle, witch hazel, hops, henna, chamomile, burdock root, horsetail, hawthorn, linden, almond, aloe vera, spruce needle, horse chestnut, sandalwood, juniper, coconut, mango, apricot , Lime, wheat, kiwi, melon, orange, grapefruit, sage, rosemary, birch, mallow, valerian, meadowfoam, quenelle, yarrow, thyme, lemon balm, toadstool, coltsfoot, marshmallow, meristem, ginseng, coffee, cocoa, moringa, ginger root and Ayurvedic plant extracts such as Aegle Marmelos (Bilwa), Cyperus Rotundus (Nagar Motha), Emblica Officinalis (Amalki), Morida Citrifolia (Ashyuka), Tinospora Cordifolia (Guduchi), Santalum album, (Chandana), Crocus Sativus (Kumkuma), Cinnamonum Zeylanicum and Nelumbo nucifera (Kamala), sweet grasses such as wheat, barley, rye, oats, spelled, maize, the various varieties of millet (millet, crab, millet as examples), cane, ryegrass, Meadow foxtail, oat grass, ostrich grass, meadow fescue, whistling grass, bamboo, cotton grass, lamprey grass, Andropogonodeae (Imperata Cylindrica also called flame grass or cogon grass), buffalo grass, silt grass, canine grasses, love grasses, cymbopogon (lemongrass), oryzeae (rice), zizania (wild rice) , Seagrass, perennial grasses, honey grasses, quaking grasses, bluegrasses, couch grass and Echinacea, especially Echinacea purpurea (L.) Moench, all types of wine and Perikarp preferred by Litchie chinensis.

The plant extracts can be used according to the invention both in pure and in diluted form. If they are used in diluted form, they usually contain about 2-80 wt .-% of active substance and as a solvent used in their extraction agent or extractant mixture.

Occasionally it may be necessary to use anionic polymers. Examples of anionic monomers from which such polymers may consist are acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid. At the same time acidic groups can be quite or partially present as a sodium, potassium, ammonium, mono- or triethanolammonium salt. Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid.

Anionic polymers which contain 2-acrylamido-2-methylpropanesulfonic acid as the sole or co-monomer can be found to be particularly effective, it being possible for all or some of the sulfonic acid group to be present as sodium, potassium, ammonium, mono- or triethanolammonium salt ,

More preferably, the homopolymer of 2-acrylamido-2-methylpropansulfon acid, which is available for example under the name Rheothik ^® 11-80 is commercially.

Preferred nonionic monomers are acrylamide, methacrylamide, acrylic esters, methacrylic esters, vinylpyrrolidone, vinyl ethers and vinyl esters.

Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with sulfonic acid-containing monomers. Such a polymer is contained in the commercial product Sepigel ^® 305 from SEPPIC.

Likewise preferred anionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene may be preferred crosslinking agents. Such compounds are for example available under the trademark Carbopol ^® commercially.

Copolymers of maleic anhydride and methyl vinyl ether, especially those with crosslinks, are also color-retaining polymers. A 1.9-decadienes crosslinked maleic acid-methyl copolymer available under the name Stabileze® ^® QM.

The anionic polymers are preferably contained in the agents according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.

In a further embodiment, the agents according to the invention may contain nonionogenic polymers.

• – Vinylpyrrolidon/Vinylester-Copolymere, wie sie beispielsweise unter dem Warenzeichen Luviskol^® (BASF) vertrieben werden. Luviskol^® VA 64 und Luviskol^® VA 73, jeweils Vinylpyrrolidon/Vinylacetat-Copolymere, sind ebenfalls bevorzugte nichtionische Polymere.
• – Celluloseether, wie Hydroxypropylcellulose, Hydroxyethylcellulose und Methylhydroxypropylcellulose, wie sie beispielsweise unter den Warenzeichen Culminal^® und Benecel^® (AQUALON) und Natrosol^®-Typen (Hercules) vertrieben werden.
• – Stärke und deren Derivate, insbesondere Stärkeether, beispielsweise Structure^® XL (National Starch), eine multifunktionelle, salztolerante Stärke;
• – Schellack
• – Polyvinylpyrrolidone, wie sie beispielsweise unter der Bezeichnung Luviskol^® (BASF) vertrieben werden.

Suitable nonionic polymers are, for example:

• - Vinylpyrrolidone / vinyl ester copolymers, such as those sold under the trademark Luviskol ^® (BASF). Luviskol ^® VA 64 and Luviskol ^® VA 73, each vinylpyrrolidone / vinyl acetate copolymers, are also preferred nonionic polymers.
• - cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and methylhydroxypropyl cellulose, as for example under the trademark Culminal® ^® and Benecel ^® (AQUALON) and Natrosol ^® grades (Hercules) are distributed.
• - starch and its derivatives, in particular starch, such as Structure XL ^® (National Starch), a multifunctional, salt-tolerant starch;
• - shellac
• - polyvinylpyrrolidones, as such, under the name Luviskol ^® (BASF).

The nonionic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.

• – 3-Benzylidencampher, z. B. 3-(4-Methylbenzyliden)campher;
• – 4-Aminobenzoesäurederivate, vorzugsweise 4-(Dimethylamino)benzoesäure-2-ethylhexylester, 4-(Dimethylamino)benzoesäure-2-octylester und 4-(Dimethylamino)benzoesäureamylester;
• – Ester der Zimtsäure, vorzugsweise 4-Methoxyzimtsäure-2-ethylhexylester, 4-Methoxyzimtsäurepropylester, 4-Methoxyzimtsäureisoamylester, 2-Cyano-3-phenyl-zimtsäure-2-ethylhexylester (Octocrylene);
• – Ester der Salicylsäure, vorzugsweise Salicylsäure-2-ethylhexylester, Salicylsäure-4-isopropylben-zylester, Salicylsäurehomomenthylester;
• – Derivate des Benzophenons, vorzugsweise 2-Hydroxy-4-methoxybenzophenon, 2-Hydroxy-4-meth-oxy-4'-methylbenzophenon, 2,2'-Dihydroxy-4-methoxybenzophenon;
• – Ester der Benzalmalonsäure, vorzugsweise 4-Methoxybenzmalonsäuredi-2-ethylhexylester;
• – Triazinderivate, wie z. B. 2,4,6-Trianilino-(p-carbo-2'-ethyl-1'-hexyloxy)-1,3,5-triazin und Octyltriazon.
• – Propan-1,3-dione, wie z. B. 1-(4-tert.Butylphenyl)-3-(4'methoxyphenyl)propan-1,3-dion;

In a further embodiment, the agents according to the invention should additionally contain at least one UV light protection filter. UVB filters can be oil-soluble or water-soluble. As oil-soluble substances z. To name, for example:

• 3-benzylidene camphor, e.g. B. 3- (4-methylbenzylidene) camphor;
• 4-aminobenzoic acid derivatives, preferably 2-ethylhexyl 4- (dimethylamino) benzoate, 2-octyl 4- (dimethylamino) benzoate and 4- (dimethylamino) benzoic acid ester;
• Esters of cinnamic acid, preferably 4-methoxycinnamic acid 2-ethylhexyl ester, propyl 4-methoxycinnamate, isoamyl 4-methoxycinnamate, 2-ethylhexyl 2-cyano-3-phenylcinnamate (octocrylene);
• Esters of salicylic acid, preferably 2-ethylhexyl salicylate, 4-isopropylbenzyl salicylate, homomenthyl salicylate;
• Derivatives of benzophenone, preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone;
• Esters of benzalmalonic acid, preferably di-2-ethylhexyl 4-methoxybenzmalonate;
• - Triazine derivatives, such as. 2,4,6-trianilino (p-carbo-2'-ethyl-1'-hexyloxy) -1,3,5-triazine and octyltriazone.
• - Propane-1,3-dione, such as. B. 1- (4-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione;

• – 2-Phenylbenzimidazol-5-sulfonsäure und deren Alkali-, Erdalkali-, Ammonium-, Alkylammonium-, Alkanolammonium- und Glucammoniumsalze;
• – Sulfonsäurederivate von Benzophenonen, vorzugsweise 2-Hydroxy-4-methoxybenzophenon-5-sul-fonsäure und ihre Salze;
• – Sulfonsäurederivate des 3-Benzylidencamphers, wie z. B. 4-(2-Oxo-3-bornylidenmethyl)benzolsul-fonsäure und 2-Methyl-5-(2-oxo-3-bornyliden)sulfonsäure und deren Salze.

Suitable water-soluble substances are:

• 2-phenylbenzimidazole-5-sulfonic acid and its alkali metal, alkaline earth metal, ammonium, alkylammonium, alkanolammonium and glucammonium salts;
• Sulfonic acid derivatives of benzophenones, preferably 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its salts;
• - Sulfonic acid derivatives of 3-Benzylidencamphers, such as. B. 4- (2-oxo-3-bomylidenemethyl) benzenesulfonic acid and 2-methyl-5- (2-oxo-3-bomylidene) sulfonic acid and salts thereof.

As a typical UV-A filter in particular derivatives of benzoylmethane are suitable, such as 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione or 1-phenyl-3 (4'-isopropylphenyl) -propane-1,3-dione. Of course, the UV-A and UV-B filters can also be used in mixtures. In addition to the soluble substances mentioned, insoluble pigments are also suitable for this purpose, in particular finely dispersed metal oxides or salts, for example titanium dioxide, zinc oxide, iron oxide, aluminum oxide, cerium oxide, zirconium oxide, silicates (talc), barium sulfate and zinc stearate. The particles should have an average diameter of less than 100 nm, preferably between 5 and 50 nm and in particular between 15 and 30 nm. They may have a spherical shape, but it is also possible to use those particles which have an ellipsoidal or otherwise deviating shape from the spherical shape.

• – Strukturanten wie Maleinsäure und Milchsäure,
• – Quellmittel wie Harnstoff, Allantoin, Carbonate oder Hydantoin,
• – Dimethylisosorbid und Cyclodextrine,
• – Farbstoffe zum Anfärben des Mittels,
• – Antischuppenwirkstoffe wie Piroctone Olamine, Zink Omadine und Climbazol,
• – Komplexbildner wie EDTA, NTA, β-Alanindiessigsäure und Phosphonsäuren,
• – Trübungsmittel wie Latex, Styrol/PVP- und Styrol/Acrylamid-Copolymere
• – Perlglanzmittel wie Ethylenglykolmono- und -distearat sowie PEG-3-distearat,
• – Pigmente,
• – Stabilisierungsmittel für Wasserstoffperoxid und andere Oxidationsmittel,
• – Treibmittel wie Propan-Butan-Gemische, N₂O, Dimethylether, CO₂ und Luft,
• – Antioxidantien,
• – Parfümöle, Duftstoffe und Riechstoffe.

Furthermore, the cosmetic agents may contain other active ingredients, auxiliaries and additives, such as

• - structurants such as maleic acid and lactic acid,
• Swelling agents such as urea, allantoin, carbonates or hydantoin,
• Dimethylisosorbide and cyclodextrins,
• Dyes for staining the agent,
• Anti-dandruff agents such as Piroctone Olamine, Zinc Omadine and Climbazole,
• Complexing agents such as EDTA, NTA, β-alaninediacetic acid and phosphonic acids,
• Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers
• Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate,
• - pigments,
• Stabilizing agent for hydrogen peroxide and other oxidizing agents,
• Propellants such as propane-butane mixtures, N ₂ O, dimethyl ether, CO ₂ and air,
• - antioxidants,
• - Perfume oils, fragrances and fragrances.

With regard to further optional components and the amounts of these components used, reference is expressly made to the relevant manuals known to the person skilled in the art.

A second subject of the invention is therefore a method for hair treatment, in which a hair treatment composition according to claim 1 is applied to the hair and is rinsed by the hair after a contact time.

The exposure time is preferably a few seconds to 100 minutes, more preferably 1 to 50 minutes and most preferably 1 to 30 minutes.

According to the invention is also a method in which a cosmetic composition according to claim 1 is applied to the hair and remains there. By "remaining on the hair" is understood according to the invention that the agent is not rinsed out of the hair immediately after its application. Vielmahr the remedy in this case remains more than 100 minutes to the next hair wash on the hair.

The following examples are intended to illustrate the subject matter of the present invention without, however, limiting it.

Examples

All quantities are, unless otherwise stated, parts by weight. The following formulations were provided using known manufacturing methods Hair Conditioner: S1 Stenol 1618 3.0 Genamine KDPM 2.0 Rheocare Ultragel 2.0 Dehyquart 180 0.5 Ubuntu Mafura Virgin 0.5 isopropyl 0.4 DC 200, 60.000cSt 0.3 methylparaben 0.2 Perfume 0.3 phenoxyethanol 0.4 water ad 100

The pH of all formulations has been adjusted to 2 to 4. K1 Stenol 1618 6.0 Quartamine BTC 131 1.5 Crodazosoft DBQ 1.5 Rheocare Ultragel 3.0 taurine 1.0 Ubuntu Mafura Virgin 1.0 isopropyl 0.4 DC 200, 60.000cSt 0.3 Cetiol C5 1.0 methylparaben 0.2 Perfume 0.3 phenoxyethanol 0.4 water ad 100

The pH of all formulations was adjusted to 2 to 4.

QUOTES INCLUDE IN THE DESCRIPTION

This list of the documents listed by the applicant has been generated automatically and is included solely for the better information of the reader. The list is not part of the German patent or utility model application. The DPMA assumes no liability for any errors or omissions.

Cited patent literature

• EP 1887024A1 [0075, 0075]

Cited non-patent literature

• "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry and Fragrance Association 1101 17th Street, NW, Suite 300, Washington, DC 20036-4702) [0115]

Claims (10)

Hair treatment compositions containing - based on its weight - d) 0.001 to 5 wt .-% Kalahari Melon oil and e) 0.1 to 10.0 wt .-% of a quaternary ammonium compound selected from the group - the esterquats and / or The quaternary imidazolines of the formula (Tkat2),

in which the radicals R are each independently of the other a saturated or unsaturated, linear or branched hydrocarbon radical having a chain length of 8 to 30 carbon atoms and A is a physiologically acceptable anion, and / or - the amines and / or cationized amines and / or - Poly (methacryloyloxyethyltrimethylammonium compounds) and / or; Quaternized cellulose derivatives, in particular polyquaternium 10 and / or polyquaternium 67, and / or cationic alkylpolyglycosides and / or cationized honey and / or cationic guar derivatives and / or chitosan and / or polymeric dimethyldiallylammonium salts and copolymers thereof Esters and amides of acrylic acid and methacrylic acid and / or copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate and / or - vinylpyrrolidone-vinylimidazoliummethochloride copolymers and / or - quaternized polyvinyl alcohol and / or - Polyquaternium 2 and / or - Polyquaternium-7 and / or polyquaternium-16 and / or polyquaternium 17 and / or polyquaternium 18 and / or polyquaternium 24 and / or polyquaternium 27 and / or f) 0.1 to 10% by weight of at least one nourishing fatty component the groups c1) of the silicones and / or c2) the oil bodies, Hair treatment composition according to claim 1, characterized in that a vitamin of the B series is contained as further active ingredient. Hair treatment composition according to one of claims 1 or 2, characterized in that the silicones are selected from the dimethicones, the arylated dimethicones, the dimethiconols, the amino-functional dimethicones, the quaternary silicones and the volatile silicones. Hair treatment composition according to claim 4, characterized in that the silicone has a viscosity of 40,000 to 80,000 mPa · s, measured at 25 ° C by means of a glass capillary viscometer according to the Dow Corning Corporate Test Method CTM 0004 of 20 July 1970, and is selected from the Dimethicones, the arylated dimethiconones, the amino-functional silicones or dimethiconols. Hair treatment composition according to one of claims 1 to 4, characterized in that further at least carnitine is included. Hair treatment composition according to one of claims 1 to 4, characterized in that further at least one purine, in particular caffeine, is included. Hair treatment composition according to one of claims 1 to 4, characterized in that further at least Ectoin is included. Hair treatment composition according to one of claims 1 to 4, characterized in that further at least one ubiquinone, in particular coenzyme Q-10, is contained. Process for the treatment of keratinic fibers, characterized in that a hair treatment composition according to any one of claims 1 to 8 is applied to the keratinic fibers and rinsed again after a contact time of a few seconds up to 45 minutes. Use of a composition according to any one of claims 1 to 8 - to improve wet and dry combabilities, - to improve the shine, - To improve the moisture balance of keratinic fibers as well To protect the keratinic fibers from oxidative damage, - To prevent the greasing of keratinous fibers as well - To increase the wash resistance of dyed keratinic fibers.